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Abstract
The 2D binary multileaf collimator (2D-bMLC) is a novel collimator concept specially dedicated
to fast rotational radiotherapy treatments. The 2D-bMLC consists of individually controlled
absorber channels arranged side by side to form a 2D aperture. The design, which leads to
radiation fields characterized by a striped pattern, aims at very quick aperture modulations.
Using a Monte Carlo (MC) method we established the dosimetric model of a theoretical flat-
tening filter free medical linac equipped with a 2D-bMLC. We further developed a treatment
planning system for rotational 2D-bMLC treatments with a new optimization method and a
MC framework for exact calculation of the dose. In plan comparison studies, 2D-bMLC plans
were calculated for various clinical indications and compared to clinically accepted IMRT and
Helical Tomotherapy plans. The design of the 2D-bMLC might be especially sensitive to geo-
metrical misalignments of the collimator on the one hand, and to intrafraction motion on the
other hand. Both aspects have been investigated in additional MC studies. The results of
the planning studies showed that the 2D-bMLC concept is in principal adequate for rotational
radiotherapy treatments with potential delivery times considerably below those of IMRT tech-
niques applied in the clinics today. Clinically acceptable 2D-bMLC plans with delivery times
below 30 seconds were calculated for all investigated tumour sites. Dosimetric parameters were
comparable to those of the reference plans. Already very small geometrical misalignment of the
2D-bMLC can cause severe under-dosage, and especially high demands on manufacture toler-
ances as well as on quality assurance will be necessary, if a 2D-bMLC should be produced for
clinical use. Consideration of intrafraction motion, however, did not lead to significant changes
in the accumulated doses calculated for prostate plans with standard fractionation.
Zusammenfassung
Ein neuartiges Kollimatorkonzept für die Strahlentherapie mit hochenergetischen Photonen
wurde im Rahmen dieser Arbeit ausgearbeitet. Das Konzept des 2D binary multileaf collimator
(2D-bMLC) soll 2-dimensionale Anpassungen des Bestrahlungsfeldes in sehr kurzer Zeit er-
lauben und wurde speziell für schnelle intensitätsmodulierte Rotationstherapie entworfen. Der
2D-bMLC besteht aus Absorberkanälen, die nebeneinander in einer 2D-Matrix angeordnet sind.
Jeder Kanal wird einzeln angesteuert, um geöffnet oder geschlossen zu werden. Mit der Monte-
Carlo-Methode (MC) wurde erfolgreich das dosimetrische Modell eines theoretischen Bestrah-
lungsgerätes etabliert. Zudem wurde ein Bestrahlungsplanungssystem entwickelt, das sich aus
einem Tool für die inverse Optimierung von Behandlungsplänen und einem MC-Tool für exakte
zeitaufgelöste Dosisberechnung zusammensetzt. In Planungsstudien wurden 2D-bMLC-Pläne
für verschiedene klinische Indikationen berechnet und mit klinisch akzeptierten IMRT- und
Tomotherapy-Plänen verglichen. Zusätzliche MC-Studien wurden durchgeführt, um den Einfluss
von geometrischen Toleranzen bei Herstellung und Installation des Kollimators und von Bewe-
gungen des Patienten während der Bestrahlung (intrafraktionellen Bewegungen) abzuschätzen.
In den Planungsstudien konnten für alle behandelten Fälle klinisch akzeptable 2D-bMLC-Pläne
mit Behandlungszeiten unter 30 Sekunden berechnet werden. Im visuellen Vergleich und in
Bezug auf die ausgewerteten dosimetrischen Parameter waren die Dosisverteilungen vergleich-
bar mit denen der Referenzpläne. Bereits relativ kleine geometrische Ungenauigkeiten bei der
Aufhängung des Kollimators können schwerwiegende Unterdosierungen verursachen. Bei einer
technischen Realisierung des Konzeptes müssten deshalb besonders hohe Anforderungen an
Herstellung, Installation und Qualitätssicherung des Bestrahlungsgerätes gestellt werden. Be-
rücksichtigung von intrafraktionellen Bewegungen bei Prostatabestrahlungen führte hingegen
bei konventioneller Fraktionierung nicht zu signifikanten Veränderungen der geplanten Dosis-
verteilungen.
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Outline
In this thesis, we present a novel collimator concept which is specially dedicated to fast rotational
radiotherapy treatments and to which we have given the name: 2D binary multileaf collimator
or 2D-bMLC in short. The goal of the presented work was to explore the potential capabilities
of the concept in modelling the physics of the dose delivery and in applying this for patient
planning studies.
In chapter 1 we give a short introduction to the basics of radiation oncology and to modern
radiotherapy techniques. In chapter 2 the 2D-bMLC concept is presented in depth, as well as
its dosimetric model that was established with a Monte Carlo method. The newly developed
treatment planning framework for fast rotational 2D-bMLC treatments is described in chapter
3, together with a first plan comparison study. Additional planning studies, that were performed
to investigate the influence of certain treatment parameters on the final dose distributions, are
grouped together in chapter 4. The design of the 2D-bMLC might be especially sensitive to
geometrical misalignments of the collimator on the one hand, and to patient motion occurring
during treatment delivery (intrafraction motion) on the other hand. Both aspects have been
investigated in the Monte Carlo studies presented in chapter 5.
Parts of this work have been published - in accordance with the regulations of the Combined
Faculties for the Natural Sciences and for Mathematics at the University of Heidelberg - in a
peer-reviewed journal article (Altenstein et al., 2012b) and have been presented on international
conferences (Altenstein et al., 2012a,c, 2013a,b, 2014).
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Chapter 1
General Introduction
1.1 Basics of Radiotherapy
1.1.1 The aim of radiotherapy
Radiotherapy is one of the most common treatments for cancer. It uses ionizing radiation to kill
the cancer cells. This can be achieved, if the DNA of the cancer cell is damaged by ionizations.
On the one hand, the primary radiation particles or rather their secondary electrons can ionise
the DNA molecule directly. On the other hand, ionisation and scattering events at water
molecules lead to the production of free radicals, which diffuse within the cell and may undergo
chemical reactions with the DNA molecule. Finally, a variety of types of damage in DNA can
be produced. If the mechanisms of DNA repair fail, the damages may be lethal to a cell. Of
course, ionizing radiation can kill both malignant and healthy cells.
In radiation physics the term dose, or absorbed dose is defined as the energy absorbed per unit
mass of medium (D = dEdM ). Its SI unit is gray (Gy), which is defined as 1 Joule of energy
per kilogram of medium. The aim of radiotherapy is to deliver a dose to the tumour, which
is high enough to kill all the tumour cells (or as much as possible in the case of a palliative
radiotherapy), and to spare the surrounding healthy tissue as much as possible from dose.
Technically this can be a very difficult task, even if we ignore outstanding biological issues and
if we assume that we know where the cancer cells are located and which dose has to be applied.
In the history of radiotherapy again and again, technological efforts have been made to better
conform the doses to the tumour.
1.1.2 A clinical treatment plan
A typical clinical treatment plan for a radiotherapy comprises, besides the diagnosis and the aim
of the treatment, the definition of one or several target volumes as well as the dose prescription
and the fractionation scheme. Target volume definitions are covered in the next section. The
fractionation scheme specifies the number of fractions in which the treatment is subdivided,
the fraction size and the time schedule for delivery of the fractions. Primarily, the total dose is
fractionated for biological reasons. Fractionation allows the irradiated tissue time to recover.
Typically, the cell repair mechanisms work better in healthy than in malignant cells, and thus,
the tissue recovery is much more efficient. In simple terms, fractionation can introduce a
differential biological effect of the treatment for the tumour and for the surrounding normal
tissue.
Typically, the limiting factor of a treatment is the toxicity induced in the organs at risk (OARs).
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Dose constraints for the OARs have to be respected in order to avoid or limit the risk of
critical radiation induced damage. Dose constraints can be introduced in the treatment plan as
maximum constraints (such as: “At any point the spinal cord should not receive a dose superior
to X Gy”) or more general dose-volume constraints (such as: “Not more than 20% of the lung
should receive doses above X Gy”).
1.1.3 Target volume definitions
Generally, in clinical practice the following volume concepts, recommended by the International
commission on Radiation Units and Measurements (ICRU) for treatment planning in external
beam radiotherapy, are used today. We quote the definitions from ICRU Report 83 (ICRU,
2010):
• The Gross Tumour Volume (GTV) is the gross demonstrable extent and location of
the tumour. The GTV may consist of a primary tumour, metastatic regional node(s), or
distant metastasis.
• The Clinical Target Volume (CTV) is a volume of tissue that contains a demonstra-
ble GTV and/or sub-clinical malignant disease with a certain probability of occurrence
considered relevant for therapy. [...] The notion of sub-clinical malignant disease includes
the microscopic tumour spread at the boundary of the primary-tumour GTV [...], the
possible regional infiltration into lymph nodes, and the potential metastatic involvement
of other organs (e.g., brain), despite their normal appearance on clinical and radiological
examinations.
• The Planning Target Volume (PTV) is a geometrical concept introduced for treatment
planning and evaluation. It is the recommended tool to shape absorbed-dose distributions
to ensure that the prescribed absorbed dose will actually be delivered to all parts of
the CTV with a clinically acceptable probability, despite geometrical uncertainties such
as organ motion and setup variations. It is also used for absorbed-dose prescription
and reporting. It includes the CTV and margins which are added around the ladder to
compensate for the effects of organ and patient movements and inaccuracies in beam and
patient set up.
Furthermore, depending on the clinical situation, it might be useful to determine separately
an internal and an external margin. The internal margin accounts for organ motion or more
precisely for uncertainties in size, shape, and position of the CTV within the patient. The
external margin accounts for possible variations in patient and beam position. Both margins
should be added quadratically to result in the final CTV-to-PTV margin. More details about
volume and margin definitions can be found in the ICRU Reports 50, 62 and 83. (ICRU, 1993,
1999, 2010).
1.2 External Beam Radiotherapy with X-Rays
Both high-energetic photons and accelerated charged particles, such as electrons, protons and
ions, are used in the treatment of cancer. Since several decades, the most commonly applied
form of radiotherapy is external beam radiotherapy with mega-voltage X-rays. The treatments
are performed with so called medical linear accelerators (linacs).
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1.2. External Beam Radiotherapy with X-Rays
1.2.1 Medical Linacs
In medical linacs, electrons are accelerated to kinetic energies from 4 to 25 MeV. The ac-
celerated electrons are guided to the treatment head and directed onto a target to produce
bremsstrahlung X-rays. Compared to the linacs used for high-energy physics research, medical
linacs are compact machines. Typically they are mounted isocentrically, which means that the
treatment head can move around in order to aim the radiation beam toward the patient from
various directions. In figure 1.1, we show a common design configuration for an isocentrically
mounted medical linac.
A special case of a medical linac is the tomotherapy unit, the design of which is shown in figure
1.2. The linac is installed in a ring-like gantry, similar to that of a CT scanner. During a
tomotherapy treatment, fan-beams are delivered to the patient meanwhile the gantry rotates.
The gantry rotation is synchronised with a longitudinal translation of the couch, which ensures
that the patient is transported trough the gantry bore. The result is a helical dose delivery.
(Jeraj et al., 2004; Mackie et al., 1999; Welsh et al., 2002)
Here, we are not going into the technical details of medical linacs. More information can be
found in textbooks such as (Podgorsak, 2010) or (Metcalfe et al., 2007). These books also
cover the physical basics of radiotherapy including the interaction properties of photons and
electrons.
1.2.2 Flattening filter free beams
In the MeV energy range the bremsstrahlung distribution from photon is strongly forward
peaked. To compensate for this effect conventional medical linacs were to date equipped with
a flattening filter (FF). The FFs are placed in the treatment head downstream the target
to produce flat dose profiles. Flat dose profiles substantially facilitated dose calculation and
treatment planning when computers where not yet used for these purposes.
A FF is usually made of medium or high Z material. It has a conical shape with a thickness of
several centimetres at its center (Izewska, 1993). Consequently, the FF affects the dose rate of
the medical linac. Furthermore, FF scatter photons are one of the major sources of treatment
head scatter. If non-uniformity of the photon fluence is not required, the removal of the FF
can therefore be advantageous by means of reducing head scatter and by allowing higher dose
rates. Modern intensity modulated treatment techniques (see section 1.3.2) in principle do not
require flattened beams. These techniques have stimulated the increasing interest in unflattened
beams, and today several treatment units are already on the market, which can be operated
clinically in a flattening filter free (FFF) mode. (Cashmore, 2008; Dzierma et al., 2012; Georg
et al., 2011; Kragl et al., 2009; Pönisch et al., 2006; Vassiliev et al., 2006)
In figure 1.3, we show lateral fluence profiles measured for the FF and the FFF mode of a
modern medical linac.
1.2.3 Multileaf collimator
In the history of radiotherapy, several collimation systems have been proposed for shaping the
radiation fields of medical linacs. Today the by far most widely used device is the multileaf
collimator (MLC) that was first commercially introduced in the late 1980s. Since then, the
MLC techniques have been refined and developed further, but essentially the principle is the
same. An MLC consists of two opposing banks of thin leafs of a high atomic numbered material,
usually tungsten. Each leaf is controlled by a motor and can be moved independently in and out
15
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1.2. External Beam Radiotherapy with X-Rays
Collimator
In-line
linac
Ring gantry
Figure 1.2: The tomotherapy unit is a special case of a medical linac which delivers ra-
diation to the patient in a helical way. This is obtained by concurrent gantry rotation and
couch/patient travel. The radiation field is fan-shaped with a variable lateral width (slice
thickness) of up to 5 cm. A very fast pneumatically driven collimator with leafs arranged in a
row is used to modulate the fan beam.
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Figure 1.3: Relative lateral profiles of the primary energy fluence measured for the Siemens
ARTISTE 160 MLC
TM
with flattening filter and with the flattening filter removed. The accel-
eration voltage was 6MV in both cases. The profiles were measured in the isocentric plane of
the treatment machine and were normalized to the central axis respectively. The dose rate is
up to almost nine times higher in FFF mode than in FF mode.
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of the path of the radiation field. Originally proposed to replace casting blocks as beam shaping
devices, the computerised MLC can generate arbitrary field shapes very efficiently. However,
as shown in figure 1.4(a) the finite width of the leafs yields a stair-stepping effect in the field
shapes.
In general, in the treatment head of a medical linac the radiation field is pre-collimated by
primary jaw pairs before the MLC defines the final aperture. MLCs are characterised by
mechanical and geometrical parameters such as the maximum field size and the leaf resolution.
Common values for the leaf resolution are 2-10 mm. The total number of leafs is often above
100. For a more detailed description we refer to the literature, e.g. to (Webb, 1997).
1.3 Delivery Techniques
1.3.1 Conformal radiation therapy
In the following we will shortly introduce conformal radiation therapy (CRT) and intensity
modulated radiation therapy (IMRT). As illustrated in figure 1.4, the idea of CRT is to conform
the radiation field to the planning target (PTV) volume and to block out critical organs at risk
(OAR) at the same time. In order to optimize the dose coverage of the PTV and minimize the
dose to the OARs treatment fields can be applied from different directions.
PTV
gantry
OAR
OA
R
ga
nt
ry
gantry
gantry
(a) Radiation fields are delivered subsequently from
different gantry angles.
(b) Hypothetical MLC aperture (beams eye view).
The MLC shape is adapted to the PTV outline.
Figure 1.4: Conformal radiation therapy (CRT). The idea is to conform the radiation fields
to the PTV and to block out critical structures. Several beams can be delivered with varying
treatment parameters such as the gantry angle and the MLC shape.
In the sketch in figure 1.4(a) fields are applied from different gantry angles. The fields would
be delivered subsequently. Radiation is switched off meanwhile the gantry is moved from one
treatment position to the next and meanwhile the MLC is adapted. In principal, not only the
gantry rotation but all geometrical degrees of freedom of a medical linac can be exploited (see
figure 1.1). Furthermore, wedge filters can be used in order to produce a gradient of intensity
within a field. Some linacs also provide several acceleration voltages. All treatment parameters
are set out in the physical treatment plan, generally established with aid of computer programs.
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1.3.2 Intensity modulated radiation therapy
If we disregard the intensity differences of the X-ray beam produced in the treatment head of
a linac, one individual collimator aperture produces a binary intensity distribution. The MLC
aperture shown in figure 1.4(b) would e.g. produce the intensity map illustrated in figure 1.5(a).
As the name suggests, the idea of intensity modulated radiation therapy (IMRT) is to modulate
the fluence of the incoming beams. The added flexibility can be utilized to better conform the
resulting dose distribution to the target volume. The modulation is thereby not limited to the
one-dimensional gradients produced by wedges that were mentioned above. In principal, any
deliverable two-dimensional modulation might be allowed. In figure 1.5(b), we show a potential
intensity map that could be realised with a MLC. To achieve this kind of modulation, several
beams from the same direction but with different MLC apertures are superimposed, that means
applied one after another. (Bortfeld, 2006)
1.3.3 Inverse planning
IMRT as it is practised today became possible with the concept of inverse planning that was
first introduced by Brahme (1988). The following quote from Brahmes paper summarises the
goal of inverse planning and the conceptual difference to conventional forward planning:
Current treatment planning procedures generally employ a trial and error type of
approach in testing various beam combinations in order to find the best irradi-
ation technique for a given target volume. In this investigation the reverse ap-
proach has been taken, that is: Given the desired dose distribution [. . . ], how
should the incident beams best be shaped in order to generate this distribution?
(Brahme, 1988)
Generally, the problem is solved with computers with planning software specially dedicated to
IMRT planning. A typical inverse planning procedure performed with a treatment planning
system (TPS) for IMRT is outlined briefly in the following. The TPS requires the user to
pre-define certain treatment parameters, such as e.g. the linac energy or the beam directions
(which parameters have to be set finally depends on the TPS and the delivery technique).
For each beam direction, the TPS assesses automatically a MLC aperture which encloses the
complete target volume, such as the aperture shown in figure 1.4(b). The resulting apertures
are subdivided into beam elements or ‘bixels’. The weights of the bixels are the free variables
which have to be determined in an inverse optimization.
Typically, the optimization algorithms used for this purpose rely on a pre-calculated so called
‘dose influence matrix’. The elements of the dose influence matrix are the dose contributions
from each bixel to each volume element (voxel) of the patient geometry. The dose calculation
engine of the TPS is used to assessed the dose influence matrix. Finally, before the optimization
of the bixel weights can be performed, the optimization goals have to be specified by the user.
A common approach is to define a number of constraints, expressed as lower and upper dose
limits for the target volume and relevant organs. Additionally, the user specifies priority values
associated to each constraint.
The result of the optimization is a fluence map (or fluence weight map) for each beam direction.
The maps could e.g. be similar to the one shown in figure 1.5(b). Once the optimization is
completed, the fluence maps have to be translated into sets of deliverable MLC fields. This
non-trivial terminal step of the planning procedure, referred to as the sequencing step, is also
handled by the TPS. The superposition of the proposed field segments should be as close as
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(a) Binary intensity map (b) Modulated intensity map
Figure 1.5: (a) In 3D conformal radiation therapy (CRT), field shaping is used alone and the
field intensities across the shape are constant. The corresponding MLC aperture is shown in
figure 1.4(b). (b) In intensity modulated radiation therapy (IMRT) the intensities across the
field shape are modulated.
possible to the optimal fluence maps. However, generally the number of final segments is
limited by the TPS or its user in order to assure reasonable delivery times and to respect the
practical limits and tolerances of the treatment machines. Therefore, the sequencing can lead to
degradations in plan quality compared to the plan associated to the actual optimization result.
Of course, the methods for treatment planning were described here very briefly. Also we did not
introduce other planning strategies such as e.g. direct aperture optimization (Shepard et al.,
2002). More details about treatment planning and the different algorithms can be found in the
literature, e.g. in (Webb, 2003, 2005). The inverse planning method developed as part of this
thesis is described in detail in chapter 3.
1.3.4 Rotational IMRT
In ‘conventional’ IMRT, as it is practised in the clinics since the late 1990s, the gantry stops
at fixed angles before beams are applied. At each stop several MLC segments are delivered as
discussed before. This delivery techniques is also referred to as fixed-field IMRT (figure 1.6(a)).
In newer techniques, that can be summarised under the term of rotational IMRT or Volumetric
Modulated Arc Therapy (VMAT), the gantry is rotating and MLC-shaped beams are delivered
at the same time (figure 1.6(b)). Intensity modulation is achieved by varying beam shape, dose
rate and/or gantry speed meanwhile the gantry rotates. A treatment can be performed in one
or several gantry rotations.
Several VMAT techniques that can be performed with a MLC equipped medical linac have been
proposed (Otto, 2008a; Ulrich et al., 2007a; Wang et al., 2008; Yu, 1995). Large-scale clinical
implementations did start in 2008, when the two linac vendors Varian and Elekta introduced
their solutions, which are marketed under the names RapidArcTM (Varian) and VMATTM
(Elekta). A historical introduction and a current overview over VMAT techniques can be found
in Yu and Tang (2011).
In section 1.2, the tomotherapy unit was shortly presented as a special case of a medical linac.
Actually, helical tomotherapy is also a rotational IMRT techniques. Helical tomotherapy is
applied in the clinics since 2003 and is often stated as the current ’Gold Standard’ in IMRT de-
livery concerning target dose conformity. Of course the technique is conceptually very different
to the VMAT techniques (see also section 1.2 and figure 1.2).
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Figure 1.6: In fixed-field IMRT, the gantry stops at fixed angles before beams are applied.
In contrast, in rotational IMRT beams are delivered meanwhile the gantry rotates.
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Chapter 2
The 2D-bMLC Concept and Its
Dosimetric Characterisation Using
Monte Carlo Simulations
2.1 Overview
In this chapter, we present the novel technical concept of a 2D binary multileaf collimator
(2D-bMLC). The 2D-bMLC consists of individually controlled absorber channels, which are
arranged side by side forming a 2D collimator aperture. The design should allow for very quick
aperture changes and is specially designed for fast dose delivery in rotational IMRT. The 2D-
bMLC concept is introduced in section 2.3.1, and more technical details as well as possible
design variations are given in appendix 2.B.
To determine the dosimetric properties of the 2D-bMLC, we designed a Monte Carlo model of
a treatment machine equipped with an exemplary 2D-bMLC consisting of 30 by 30 channels
(section 2.3.3). A virtual source model of a flattening filter free 7MV linac was used was used
to characterise the linac phase space (appendix 2.A). The dosimetric evaluation included the
primary radiation efficiency and the leakage dose of the collimator as well as the characterisation
of individual channel beams. Possible tongue-and-groove effects of abutting channel beams were
also investigated. The results are presented in section 2.4.
The successfully established dosimetric model of the 2D-bMLC was the basis for the develop-
ment of a planning framework for rotational 2D-bMLC therapy, which we present in chapter
3.
Publication
Sections 2.2 to 2.6 have been published in Altenstein et al. (2012b). Results from this chapter
have been presented at the international ESTRO 31 Conference in Barcelona, Spain, May 2012
(Altenstein et al., 2012a).
2.2 Introduction
Intensity-modulated radiation therapy (IMRT) is a widely accepted treatment technique, and
its adoption into clinical practise has advanced far in the last decade. Most photon IMRT
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treatments are realised with standard medical accelerators (linac) equipped with a multileaf
collimator (MLC). In general, a large number of independent MLC-shaped 2D-beams is deliv-
ered in succession. In conventional IMRT, the gantry stops at fixed angles before beams are
applied (Bortfeld, 2006). Whereas in newer techniques, summarised under the term rotational
IMRT or Volumetric Modulated Arc Therapy (VMAT), the gantry is rotating and cone beams
are delivered at the same time. In doing so, intensity modulation is achieved by varying beam
shape, dose rate and/or gantry speed during one or more rotations. (Otto, 2008a; Ulrich et al.,
2007a; Wang et al., 2008; Yu, 1995)
Even if the conventional field-shaping MLC was originally not designed for IMRT (Webb, 2001),
its advantages for both static beam and rotational IMRT are obvious. MLCs make use of two
opposing banks of attenuating leafs, which can be positioned independently to realise a desired
field opening. The concept allows a large variety of field shapes and, with motor driven leafs,
it gives the ability to change the aperture automatically (Bortfeld, 2006). However, the time
required for these aperture changes depends on the leaf speed, and, despite many technical
advances in the past, the maximum leaf speed of modern MLCs is still limited. In IMRT
treatments, where several fields of different shape has to be applied in order to achieve the
intensity modulation, this mechanical restriction can also affect the overall delivery time of a
treatment. Typical delivery times for IMRT fractions are today in the range of several minutes.
In this chapter we present a novel IMRT collimator concept, which aims at ultra-fast aperture
modulation: A two-dimensional binary multileaf collimator (2D-bMLC). The concept is based
on the principles published in (Heid, 2010). Absorber channels, arranged side by side in a tessel-
lated pattern, form a 2D matrix collimator. The design allows individual independent control of
each channel. An open channel results in a divergent quasi-rectangular beam. Whereas in one
direction beams of adjacent channels abut, in the other direction they are separated because
half of each channel always blocks the radiation. The 2D-bMLC does not shape open fields,
like conventional MLCs do, but each element of its chequerboard like aperture can either be
closed or half open. Therefore, the design allows in principal very quick aperture changes, and
a possible application of the 2D-bMLC could be the dose delivery via fast rotational IMRT.
To evaluate the concept, we designed a Monte Carlo (MC) model of an exemplary 2D-bMLC
with 30 by 30 channels. Each channel beam had a cross-section of approximately 5 mm by 10
mm in the isocentric plane. The research question, we wanted to answer in the study presented
in this chapter, is whether the 2D-bMLC model fulfils in general the dosimetric requirements for
the use in radiotherapy treatments. The dosimetric characterisation of the model, assessed in
MC simulations with Geant4, includes the study of width and penumbra of the channel beams,
the leakage and the dose delivery efficiency of the collimator as well as tongue-and-groove effects.
2.3 Methods
2.3.1 2D-bMLC design and mode of operation
The developed 2D-bMLC model consists of 30 by 30 absorber channels, which are arranged
side by side on a spherical shell segment. In general, the collimator concept may consist of
M by N channels, whereas the numbers M and N are only restricted by geometrical limits:
For practical reasons, which will be outlined later, the covered segment of the spherical shell
cannot be extended arbitrarily. The presented model is designed for a treatment machine with
a source-to-axis distance (SAD) of 800 mm. The coordinate system used for all descriptions
of the 2D-bMLC is shown in figure 2.5(b). It corresponds to the GANTRY system defined in
(IEC 61217).
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Figure 2.1: Principle design of a 2D-bMLC channel. Here, the central channel positioned
on the z-axis of the GANTRY system is shown. The channel is focused on the source whose
center has the coordinates x=y=0mm and z=800mm. To assure correct convergence of the
channel in both states, open and closed, the central block has to be moved on a curved path.
(not to scale)
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The principle design of an absorber channel is shown in figure 2.1. Every channel consists of
three blocks made of tungsten. Two blocks are fixed one behind another with a gap in between.
The third block, denoted as the central block, can be moved between two positions: It can be
placed in the gap between the two other blocks or it can be shifted laterally out of the gap. If
all three blocks are in line (see figure 2.1 top-right), the channel is open. If the central module
is shifted in respect to the fixed ones (figure 2.1 top-left) the channel is closed. The z-lengths
of the three tungsten blocks, 40 mm, 80 mm, and 40 mm respectively, are the same for all
channels. The x- and y-lengths depend on the distance source-collimator and on the channel’s
position on the spherical shell segment. (Equations for the exact dimensions of all absorbers
are given in section 2.B.1.)
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Figure 2.2: Motors could be placed in the gaps between the absorber blocks, on both sides
of the central block.
For two main reasons, we present the configuration of the channel with three absorber blocks
and not an alternative configuration with two blocks, one fixed and one movable. First, the
configuration should minimise possible cross leakage through the blocks of a channel or across
adjacent channels. Second, the configuration allows the installation of motors on both side of
the movable central block, as it is shown in figure 2.2. The motors could be attached to the
surrounding fixed elements. Of course, the configuration entails certain requirements concerning
the size of the motors as well as the materials of their components. These engineering questions
are not part of this work, but should be addressed in further studies.
All channels are focusing on the photon source, or rather on the target of the linear accelerator
(linac). That is why we arranged the collimator channels on a spherical shell, with the linac
target in its center. If a channel is open, a divergent photon beam can directly traverse one
side of the channel. Figure 2.3 schematically shows the arrangement of the 900 channels on the
spherical shell. Each channel is represented by two adjacent trapezoids, a light grey one and a
dark grey one. If a channel is open, X-rays can traverse the channel through the light grey side.
The collimator is designed so that the beams of the most central channels have rectangular
cross-sections with the dimensions 5×10 mm2 in the isocentric plane. To realise exactly the
same dimensions for all beams, the channels on the spherical shell would have to be narrowed
in both directions, x and y. This would necessitate 900 individual channel geometries. If all
channels are open, we would then obtain a quadratic radiation field of parallel stripes in the
isocentric plane with the dimensions 300×300mm2. In contrast, in our implementation, the
channels are narrowed only in y-direction. The pattern depicted in figure 2.3 is similar to that
of latitude and longitudinal lines on a globe. As a consequence, the channels with same y-index
are identical, and the number of different geometries is reduced to 30. Therefore, due to the
selected design, the dimensions of the emerging channel beams vary slightly depending on their
position. This can be seen in the geometrical projection of the beam cross sections onto the
isocentric plane, which is shown on the right side of the figure. The resulting pattern looks like
the slightly deformed pattern of parallel stripes described above. We calculated quantitative
deviation maps from the geometrical projection. They can be found in 2.4.1. (Equations for
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the geometrical projections are given in 2.B.2.)
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Figure 2.3: The channels of the 2D-bMLC are arranged side by side on a spherical shell
around the photon source (left and middle). Each channel is represented by two adjacent
trapezoids - a dark grey one and a light grey one. The channels are narrowed in y-direction
and the pattern depicted is similar to that of latitude and longitudinal lines on a globe. The
geometrical projection of the beam cross sections onto the isocentric plane is shown on the
right side.
Now it becomes clear, why the number of collimator channels M and N cannot not be extended
arbitrarily. The farther the channels are positioned from the center of the shell segment, the
thinner they have to be designed. At a certain point, they become too thin to allow a proper
production and operation (mechanical opening and closing). Also, at least in our implemen-
tation, the “deformation” of the 2D-bMLC field (see above) becomes larger with the distance
to the center. By limiting the collimator to 30 by 30 channels, we assure that both, channel
dimensions and the non-uniformity of the field, are in a reasonable range.
2.3.2 Indexing of 2D-bMLC channels
Figure 2.4 shows how we index the channels and the corresponding beams (bixel) of the 2D-
bMLC. Two indices are assigned to each channel. The indices correspond to the columns and
rows of the 2D-bMLC matrix, whose projection to the isocentric plane is shown schematically
in the figure. Here, we omit the pattern deviations discussed in 2.3.1. The indices go both from
1 to 30, starting in the lower left corner. The first two digits of the labels represent the column
index; the second two digits represent the row index.
2.3.3 Monte Carlo evaluation of the 2D-bMLC
2.3.3.1 Monte Carlo setup
The MC setup we used to evaluate the 2D-bMLC concept is shown in figure 2.5(a). As already
mentioned the SAD is set to 800 mm. The collimator model is described in detail in 2.3.1.
Additional tungsten modules surrounding the 30 by 30 collimator channels are added to the
setup to block radiation passing the collimator on its sides. Each channel can be opened or
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Figure 2.4: Principle of indexing of the 2D-bMLC channels. Matrix of 30 by 30 channels
projected to the isocentric plane (here a regular pattern is shown without the deviations due
to the specific design of the channels).
closed individually, so that any arbitrary pattern of open and closed channels can be modelled.
A simplified virtual source model of a flattening filter free (FFF) Siemens ARTISTE 7MV 160
MLCTM was developed and used as surrogate for MC simulations of the linac phase space.
The model consists of a planar photon source located close to the bremsstrahlung target of
the linac. It represents a source of primary photons generated within the target. Since we
want to model an unflat beam, a second virtual source, normally used to model the flattening
filter, is not necessary. The standard deviation of the two-dimensional Gaussian shaped source
is 0.45 mm. A profile of the primary photon fluence and the energy spectrum of the source
photons are shown in figure 2.6. A detailed description of our source model, how it was fitted
to experimental data, and of its validation can be found in 2.A.
Upstream the collimator, the source photons can be pre-collimated by a so called cookie cut-
ter: All particles that do not pass a well defined aperture are not further simulated. In the
current implementation the aperture is quadratic with variable side length. The phase space
downstream the 2D-bMLC can be recorded in the optional phase space plane.
The phantom, a rectangular water tank, has the dimensions 500×500×400mm3. In all simula-
tions, its center is positioned on the z-axis. The source-surface distance (SSD) can be set to a
desired value. The energy dose deposit is scored within the phantom in 3-dimensional Cartesian
scoring meshes with 0.5 mm x- and y-resolution and variable z-resolution.
Statistical uncertainties
Statistical analysis was performed following the batch method. Each simulation was divided in
N batches and in every batch k the dose dki to a voxel i was calculated. After completion of all
batches, the mean dose di to a voxel and the corresponding uncertainty sdi was calculated as
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Figure 2.5: Schemes of the MC setup used for the evaluation of the 2D-bMLC (a) and of the
GANTRY coordinate system (b), which was used for all descriptions in this work.
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Figure 2.6: Virtual source model of a FFF Siemens ARTISTE 7MV 160 MLC
TM
: The
primary photon fluence was directly calculated from a diagonal dose profile measured in 15
mm depth in water at 1000 mm SAD (a). The energy spectrum (b) as well as the source size
were assessed by fitting Monte Carlo results to other experimental data. (See appendix for
more details)
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the standard error of the mean:
di =
N∑
k=1
dki
N
, sdi =
√√√√√ N∑k=1 (dki − di)2
N(N − 1) (2.1)
The fractional uncertainty in dose for voxel i was defined as
Fdi =
sdi
di
. (2.2)
In this study most evaluations were performed in 15 mm depth in water. As a measure of
statistical uncertainty of a simulation, a mean fractional uncertainty for 15mm depth in water
was calculated as follows: Fdi was averaged over all voxels at 15mm depth and with a local
dose deposit greater than 25% of the maximum dose at the same depth. The total number of
primary particles was set for each simulation to ensure the following maximum mean fractional
uncertainties in 15 mm depth in water: 2% for the simulations described in 2.3.3.4 and 2.3.3.5
and 5% for the simulations described in 2.3.3.3. For final evaluation the dose distributions were
generally averaged over several voxel in one or more directions, so that relative uncertainties
were further decreased. The same is true for dose distributions and dose profiles shown in the
results section.
The simulations described in 2.3.3.4 and 2.3.3.5 were subdivided in two separate parts. In a first
part the transport of the source photons through the tungsten elements of the collimator were
simulated, and the phase space was scored in the phase space plane. In a second simulation the
particle transport through the water phantom was simulated and the spatial dose deposition
was scored. Here, a common variance reduction method was applied: Each phase space particle
was reused 20 times, but each time with different random numbers.
All MC simulations were implemented with Geant4 version 9.4p02 (Agostinelli et al., 2003). A
Geant4 standard electromagnetic physics list with best advanced electromagnetic options was
used1.
2.3.3.2 Reference field
To model an open reference field, the 2D-bMLC was removed from the setup shown in figure
2.5(a), and collimation was performed only by the pre-collimator. The SAD of 800 mm was not
changed. The side length of the reference field in the isocentric plane was 100 mm. Dose was
scored in the water phantom with 785 mm SSD. Unless otherwise noted, dose values presented
in this work were scaled to 1 million primary particles and are given relative to the dose Dref .
Dref is the dose scored in the center of the reference field in 15 mm depth in water and likewise
scaled to 1 million primaries.
2.3.3.3 Efficiency and leakage
To estimate the efficiency of the 2D-bMLC, we performed a simulation, in which the 10 by 10
central channels of the collimator were opened. The corresponding bixel pattern is shown in
figure 2.7(a). The pre-collimator was set as in the simulation for the reference field (see 2.3.3.2).
1The physics list was similar to that which is loaded with the physics list constructor emstandard_opt3. The
physics list constructors are developed and maintained by the electromagnetic working group of the Geant4
collaboration. Further information can be found on http://geant4.web.cern.ch/geant4/collaboration/
working_groups/electromagnetic/physlist.shtml.
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To quantify the influence of electron contamination to the 2D-bMLC field, we scored the in-
tegral energy fluence for different particle types downstream the collimator in the phase space
plane (see figure 2.5(a)). The relative contribution of electron contamination was estimated by
dividing the energy fluence scored for electrons (and positrons) by the energy fluence scored for
all particles.
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Figure 2.7: Matrix of 30 by 30 channels projected to the isocentric plane. Open channels are
labelled in black for the simulations described in 2.3.3.3 (a), 2.3.3.4 (b) and 2.3.3.5 (c).
A second simulation was performed in order to quantify the leakage of the 2D-bMLC. In this
simulation all collimator channels were closed. In both simulations the SSD was set to 785
mm. Quantitative evaluations were made for the dose D(x, y) scored in the isocentric plane,
respectively in a water slab at 15 mm depth.
A relative efficiency factor was calculated using
EF =
Integral Dose10×10channels
Integral Dosereference
. (2.3)
The integral dose is the dose scored in the entire slab. Integral Dose10×10channels refers to the
simulation, in which the the central 10 by 10 collimator channels were open (figure 2.7(a)).
Integral Dosereference is the integral dose calculated for the same slab in the simulation of the
reference field.
A leakage map was calculated by dividing the dose scored for the closed 2D-bMLC by Dref .
2.3.3.4 Width and penumbra of individual channel beams (bixels)
We calculated the spatial dose deposited in the water phantom by four different bixels, origi-
nating from the channels 0505, 0515, 1505, and 1515. The corresponding bixel pattern is shown
in figure 2.7(b). The limitation to bixels from one quadrant of the 2D-bMLC is justified by the
rotational symmetry of the photon source and the 2D-bMLC pattern. Again, the SSD was set
to 785 mm. The following values were estimated for every bixel from dose profiles in 15 mm
depth in water: Maximum dose, full width at half maximum (FWHM), 20%-80%-penumbra.
For this, dose profiles in x- and y-direction, going through the maximum dose deposited by
the respective bixel, were evaluated. Furthermore, the coordinates of each bixel’s center was
assessed by calculating the center between the points at half maximum of the x- and y-profiles.
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2.3.3.5 Butting channel beams
To evaluate tongue-and-groove effects, the spatial dose deposited by four adjacent bixels, num-
ber 1514, 1515, 1516, and 1517 (see figure 2.7(c)), was calculated in two different ways. In a
first MC simulation, the channels were opened simultaneously, whereas in a second simulation,
they were opened one after another. Again, the SSD was set to 785 mm. Tongue-and-groove
effects are expected because of the finite size of the photon source. To prove this, we repeated
the second simulation with an infinite small source (point source). All other parameters of the
source model were maintained.
2.4 Results
2.4.1 Deviation maps
The maps shown in figure 2.8 visualise the deviations of the geometric bixel cross sections in
the isocentric plane from a perfect regular pattern. The regular pattern is characterised by
constant bixel side lengths, 5 mm in x and 10 mm in y, and by a regular spacing of 10 mm in
both directions. The coordinates of the bixel centres would match the following grids:
x ∈ {−142.5mm, −132.5mm, −122.5mm, . . . , 147.5mm } (2.4)
y ∈ {−145.0mm, −135.0mm, −125.0mm, . . . , 145.0mm } (2.5)
In the two upper maps of the figure, the deviations of our bixel centres from the respective
coordinates given in (2.4) and (2.5) are color-coded. In the two lower maps, the side lengths of
the geometric bixel cross sections are color-coded.
In the center of our 2D-bMLC pattern, deviations to the regular pattern disappear. Here, the
bixel side lengths are very close to 5 mm respectively 10 mm, and the bixel position match
in approximation the coordinates of the regular grid. At the pattern edges the maximum side
lengths are about 5.17 mm in x and 10.17 mm in y. The maximal position deviations at the
pattern edges are about ±2 mm in x-direction and about ±3 mm in y-direction.
2.4.2 Simulation design of the 2D-bMLC
In figure 2.9, we show images of the core of our 2D-bMLC Monte Carlo model. 30 trisected
fan-like layers can be seen. They correspond to the x-indices. Each layer is composed of
30 collimator channels, placed side by side in y-direction and corresponding to the y-indices
respectively. The division of the layers is due to the design of the channels, described above
and shown in figure 2.1. Every collimator channel is made of three tungsten blocks, two fixed
blocks and one central block which can be shifted between two positions. In both images shown
in figure 2.9 all 2D-bMLC channels are open.
2.4.3 Monte Carlo evaluation of the 2D-bMLC
2.4.3.1 Efficiency and leakage
Figure 2.10 shows color maps of the dose distribution scored in 15 mm depth in water for
the reference field and for the simulation performed to assess the efficiency of the collimator.
In addition, averaged lateral profiles in x-direction are shown. The dashed rectangles in the
maps indicate over which y-range the profiles were averaged. As outlined in 2.3.3.3, the dose
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Figure 2.8: Geometrical projection of the 2D-bMLC pattern onto the isocentric plane. In x-
direction every second trapezoid corresponds to one bixel cross section in the isocentric plane.
Above: Deviations in x- and y-direction of the bixel center from the coordinates given in (2.4)
and (2.5) are color-coded. Below: The dimensions of the geometrical bixel cross sections are
color-coded.
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Figure 2.9: Cross section of the 2D-bMLC Monte Carlo model (to scale). See figure 2.5(a)
and 2.1 for more dimensions.
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distributions were scaled to the same number of primary particles and are shown relative to
Dref , whereas Dref is the dose at the center of the reference field map2. The last stripe of
the 2D-bMLC fileld in the positive x-direction seems to be diminished compared to the others.
This is due to the fact that the same pre-collimation upstream the collimator was applied as in
the simulation of the reference field. We calculated a relative efficiency factor (equation 2.3) as
EF = 0.43 .
The relative contribution of the electron contamination to the 2D-bMLC field was approximately
0.12%.
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Figure 2.10: Dose maps of an open 100×100mm2 reference field (above left) and a 2D-
bMLC field (above right). In the simulation of the 2D-bMLC the central 10 by 10 channels
were opened. The dose was scored in 15 mm depth in water (SSD 785 mm) and scaled relative
to the maximum dose scored for the reference field. For the lateral profiles below, the dose
distributions are averaged over 50 mm in y-direction (the profiles correspond to the rectangles
in the dose maps).
In figure 2.11(a) the calculated leakage map is shown. For the figure the map was averaged
over 20 by 20 neighbouring voxels to improve SNR. Because relatively few particles pass the
completely closed 2D-bMLC, the SNR of the original leakage map with a lateral resolution of
0.5 mm was too low. The relative leakage ranges from about 0.1-0.2% at the field borders to
about 0.4% in its center. The mean leakage, averaged from −150mm to 150mm in x- and
y-direction, is 0.25%. For Figure 2.11(b) we calculated lateral leakage profiles by respectively
averaging the original map in one direction, whereas the resolution in the other direction was
not changed.
2To assess Dref with satisfying statistical accuracy, the dose was averaged over several voxel in x-, y-direction.
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Figure 2.11: (a) Leakage map calculated for the closed 2D-bMLC in the isocentric plane.
(b) Lateral profiles of the leakage map. For the profiles the map was averaged over the whole
2D-bMLC field in y- and respectively in x-direction.
2.4.3.2 Width and penumbra of individual channel beams (bixel)
Figure 2.12 shows the lateral profiles of the dose deposited in 15 mm depth in water by bixel
0505, 0515, 1505, and 1515 respectively. The values presented in table 2.1 were assessed from
these profiles. The center position and the FWHM of the profiles are in agreement with the
values calculated from the geometric projection and discussed in 2.4.1. The profile’s maxima,
which are again given relative to Dref , decreases with the distance of the respective element
from the central axis of the treatment machine. The decrease follows the primary photon fluence
distribution of the source model.The 20%-80%-penumbra of all bixel profiles is 1.7−1.8 mm.
Table 2.1: Maximum, Central position (Center), full width half maximum (FWHM), and
20%-80%-penumbra of bixel profiles in the isocentric plane in 15 mm depth in water. Values
were assessed by evaluating the X- and Y-profiles shown in figure 2.12. The maximum is given
relative to the Dref defined in 2.3.3.2 .
X-profile Y-profile
Bixel Maximum Center FWHM Penumbra Center FWHM Penumbra
1515 0.76 -2.5 5.1 1.7 -5.0 10.0 1.7
1505 0.45 -2.5 5.1 1.8 -105.0 9.9 1.8
0515 0.46 -103.1 5.2 1.7 -5.0 10.1 1.8
0505 0.34 -103.1 5.2 1.7 -105.9 10.1 1.7
[a.u.] [mm] [mm] [mm] [mm] [mm] [mm]
2.4.3.3 Butting channel beams
To investigate tongue-and-groove effects, four adjacent bixel were opened simultaneously in a
first simulation and one after another in a second simulation. We compare the dose distributions
calculated in 15 mm depth in water. Lateral dose profiles in y-direction, going through the
distributions maxima at x = −5 mm, are shown in figure 2.13. The bixel do not adapt perfectly
if opened consecutively, but small minima can be observed where they abut. The dose is reduced
in these regions by up to 5% in approximation. This effect is not present if the bixels are all
open simultaneously.
In figure 2.13 on the right we also show the profile calculated for an infinite small point source.
No tongue-and-groove effect is apparent. Moreover, in all the profile is about several percent
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Figure 2.12: Lateral dose profiles of bixels 0505, 0515, 1505, and 1515 in 15 mm depth in
water. The bixel pattern corresponding to the MC simulation is shown in figure 2.7(b).
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higher then the one obtained for the finite source because of an increased primary radiation
efficiency.
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Figure 2.13: Dose profiles calculated in 15 mm depth in water for four adjacent bixel, which
were opened simultaneously or in succession. The corresponding bixels are labelled in figure
2.7(c). The lateral profiles in y-direction go through the maxima of the dose distributions
(x = −2.5 mm). On the right side in addition to the result for the Gaussian shaped finite
source, a profile calculated for a point source is shown.
2.5 Discussion
The relative intensities of the channel beams follow the primary photon fluence distribution
of the source model. The geometric widths of the most central bixel in the isocentric plane
are approximately 5 mm in one and 10 mm in the other direction. Towards the borders of
the 2D-bMLC field, the widths increase in a symmetric manner by up to 4%. The central
axes of the bixels as well as the change of their widths can be approximated by geometric
calculations. These calculations could be affirmed by the MC results. In addition, the simulation
of the individual bixels showed that the beam penumbra does not change considerably between
different bixels.
We arranged the collimator channels on a spherical shell; each channel focus on the linac source.
Compared to a collimator composed of parallel rectangular channels, our design should result
in a higher primary radiation efficiency. Certainly, because in one half of each channel the
radiation is always blocked, the efficiency cannot exceed 50%. Moreover, this value would
only be attainable for a point source, and the efficiency further decreases with the source
size. Geometric consideration suggest that the source size together with the distance source-
collimator and the dimensions of the absorber channels determine the geometric penumbra
of a bixel, and, more generally, how many particles can pass through the openings. For a
two-dimensional Gaussian shaped source with a standard deviation of 0.45 mm (FWHM=1.06
mm), we calculated a primary radiation efficiency of approximately 43% for the 2D-bMLC.
According to the consideration mentioned above, one could potentially increase the efficiency, if
the source size could somehow be reduced. Given a fixed source size, the efficiency could slightly
be improved by shortening the 2D-bMLC channels or by increasing the distance between the
source and the collimator. However, the shortening of the absorber channels would result in
higher leakage, whereas a considerable increase of the distance source-collimator would implicate
an increase of the SAD of the treatment machine.
A slight tongue-and groove under-dosage was observed, if adjacent beams were opened sub-
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sequently and not at the same time (see figure 2.13). Just as the reduced efficiency, also the
tongue-and-groove effect, is explained by the finite source size and would diminish, if all photons
would originate from one point. The under-dosage is restricted to about 2 mm in the regions
where the beams abut. The maximum relative under-dosage is approximately 5%. The effect
should be considered in a treatment planning algorithm to avoid uncertainties, even though,
the effect is less pronounced than similar tongue-and-groove effects exhibited by conventional
MLCs. If two adjacent irradiation fields of these collimators are combined, relative under-dosage
of 10-40% can be observed at the boundary line.(Huq et al., 2002; Tacke et al., 2008)
The average leakage calculated for the 2D-bMLC is 0.25%. It is mainly affected by intra-leaf
leakage, thus by the transmission through the tungsten absorbers of the collimator channels.
Only relatively weak additional inter-leaf leakage is present. The latter leads to the wiggly
character of the x-profile, shown in figure 2.11(b). The maximum of the leakage can be estimated
to about 0.4% in the center of the collimator. As the primary photon fluence distribution, the
leakage decreases with the distance to the central axis of the treatment machine. The calculated
leakage of the 2D-bMLC is in the same range of the leaf transmission measured for the ARTISTE
6MV 160 MLCTM with flattening filter (Tacke et al., 2008). Of course, additional leakage could
be caused by possible mechanical imperfections, which are not considered in the current model.
General discussion of the 2D-bMLC concept
Referring to the ideas described in (Heid, 2010), the 2D-bMLC consists of individually controlled
absorber channels, which form a two-dimensional collimator aperture in the form of a matrix.
The design aims for an easy and rapid modulation of the aperture. Arbitrary modulation
patterns could be realised with relatively short time delays, affected by the time needed to open
and close the channels. This could be an advantage of the 2D-bMLC over conventional MLC
techniques. Due to mechanical limitations of the leaf speed, subsequent modulation patterns
delivered with conventional MLC techniques are strongly correlated or considerable dead times
in between the delivery have to be accepted.
A disadvantage of the concept could be the fragmentation of the radiation field and the related
reduction in beam utilisation efficiency. Moreover, because aperture modulations are limited to
open and closed bixels, their resolution is determined by the widths of the bixels. As discussed
above the geometrical widths are approximately 5×10 mm in the isocentric plane. In contrast,
fields of modern conventional MLCs can generally be shaped with higher precision. The leafs
of the ARTISTE 6MV 160 MLCTM have for example a projected width of 5 mm (Tacke et al.,
2008). This parameter corresponds to the y-resolution in the GANTRY system. In the the
x-direction, the leaf-travel direction, the resolution is only limited by the precision of the leaf-
driving motors.
The dosimetric characterisation of the 2D-bMLC model shows that the concept can be used
for radiotherapy treatments. The 2D-bMLC fields are well defined with a maximum extent of
approximately 300 by 300 mm2 in the isocentric plane. Compared to open fields, the beam
utilisation efficiency is reduced by approximately 57%. The leakage is comparable to that
of conventional collimators, tongue-and-groove effects are of minor importance. Because of
the field fragmentation, the 2D-bMLC concept is certainly not well suited for static IMRT
treatments with only a few beam directions. However the 2D-bMLC may be used in rotational
IMRT treatments, in which beams from the continuously rotating gantry are superimposed in
the patient.
As we mentioned in the introduction, a possible application of the 2D-bMLC could be in fast
rotational IMRT. To speed up considerably rotational IMRT treatments, in a first instance, the
38
2.6. Conclusion
dose rates of medical linacs has to be increased, as it has been done in recent developments
by removal of the flattening filter (Georg et al., 2011; Salter et al., 2011). If delivery times of
rotational IMRT treatments could even be reduced to times below those of anticipated organ
movements, the motion could be ‘frozen’ during the dose delivery. This could be advantageous
in cases in which intrafraction organ or tumour motion becomes a limitation of the geometrical
accuracy of the treatment. Such a strategy could potentially be realised with a 2D-bMLC.
From the figures 2.1, 2.3 and 2.9 it is apparent that the 2D-bMLC model makes high demands
on the geometrical and mechanical precision of the collimator. Slight geometrical misalignment
of the collimator on the whole or of its components would lead to a shift of the radiation field
and eventually reduce the primary radiation efficiency. A detailed study of the influence of
geometrical and mechanical misalignment, e.g. caused by manufacturer tolerances, is one of
our next steps.
2.6 Conclusion
A novel technical concept of a two-dimensional binary collimator (2D-bMLC), specially designed
for fast dose delivery in rotational IMRT, was presented. We successfully established and
evaluated a dosimetric model of the 2D-bMLC. The results were promising and allowed us to
integrate the 2D-bMLC into the treatment planning tool that is presented in chapter 3.
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2.A Details: Source Model of Siemens ARTISTE 7MV 160 MLCTM
A simplified virtual source model of a flattening filter free (FFF) Siemens ARTISTE 7MV 160
MLCTM was developed for the use as surrogate in Monte Carlo simulations.
2.A.1 Methods
2.A.1.1 Source model
The model consists of a planar photon source located close to the bremsstrahlung target. It
represents a source of primary photons generated within the linac target. Since we want to
model an unflat beam, a second virtual source, normally used to model the flattening filter
is not necessary. The influence of other extra-focal photons and of contamination electrons is
supposed to be of minor importance and not considered.
The source is described by three independent distributions:
• A Gaussian-shaped planar source distribution dplanar (x, y)
• A circular angular distribution dangular (θ) for the direction of the source photons
• An energy distribution of the source photons denergy (E)
x and y are coordinates of the GANTRY system (figure 2.5(b)) and θ is the angle between the
photon direction vector and the central axis of the treatment machine, respectively the negative
z-axis of the GANTRY system. In reality, the energy distribution may depend on the angle θ.
This dependence is way more important for machines with flattening filter where the occurring
beam hardening depends on the angle θ. Without flattening filter the influence is of minor
importance (Dalaryd et al., 2010) and is neglected in the presented model.
To adjust the model to the FFF Siemens ARTISTE 7MV 160 MLCTM , the following procedure
was applied: First, the angular distribution dangular (θ) was assessed directly by primary fluence
measurements (see 2.A.1.3). The energy distribution and the planar distribution of the source
position were then calculated by fitting Monte Carlo (MC) results to other experimental data
(see 2.A.1.4 and 2.A.1.5).
2.A.1.2 Experimental data and MC setup
Dose measurements were carried out at the German Cancer Research Center with an experi-
mental Siemens ARTISTE 7MV 160MLCTM , the PTW MP3 water tank with the dimensions
500×500×400mm3 and the PTW 60008 Diode P. The source-axis distance (SAD) was 1000 mm
the source-surface distance (SSD) either 950 mm or 985 mm. Measurements were performed
with quadratic fields of various side length. The experimental data includes percentage depth
dose curves (PDD) and central lateral dose profiles measured in different depths in water.
The MC setup is shown schematically in figure 2.14. As (Fippel et al., 2003) suggested, a
simplified model of the collimating system was used: Two tungsten jaw pairs, denoted X-MLC
and Y-jaws, modify the x- and y-dimensions of the beam. The Y-jaws have planar inner faces
focusing the center of the photon source. The form of the X-MLC is based on a realistic
description of the multileaf collimator (Tacke et al., 2006). Adapting the jaw openings, any
rectangular field can be collimated (up to a 400×400mm2-field in the isocenter plane). The water
tank was modelled by a block of water with the respective side lengths. The dose was calculated
within the phantom in Cartesian scoring meshes. The MC simulations were implemented with
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Geant4 version 9.4 (Agostinelli et al., 2003). A Geant4 standard electromagnetic physics list
with best advanced electromagnetic options was used3.
Y-Jaws *
X-MLC *
Photon source *
Phantom
(optional)
1000 mm
778 mm
643 mm
701 mm
548 mm
 0 mm
view rotated 90°
Isocentric plane *
* simplified two-dimensional illustration
xy
z
Figure 2.14: Schemes of MC setup used for the assessment of source model parameter. The
collimating system consists of two jaw pairs with variable opening: The Y-jaws with planar
inner faces focusing the center of the photon source and the X-MLC whose form is based on a
realistic description of the MLC.
2.A.1.3 Angular distribution
The relative angular distribution was directly calculated from a dose profile measured at the
phantom surface at 15 mm depth (SSD 985 mm). At this depth, the measured dose is assumed
to be proportional to the primary photon fluence distribution. A diagonal dose profile from the
center of a 400×400mm2-field to one of its corners was assessed. di is the dose measured at the
distance ri to the center of the field. The discrete profile was converted into a discrete angular
distribution using
dangular (θi) = Nangular di
sinθi
cos2θi
(2.6)
with
θi = atan
( ri
1000mm
)
. (2.7)
3The physics list was similar to that which is loaded with the physics list constructor emstandard_opt3. The
physics list constructors are developed and maintained by the electromagnetic working group of the Geant4
collaboration. Further information can be found on http://geant4.web.cern.ch/geant4/collaboration/
working_groups/electromagnetic/physlist.shtml.
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Nangular is a normalisation factor. Finally, the angular distribution was interpolated to a finer
θ-grid.
2.A.1.4 Energy distribution
(Fippel et al., 2003) proposed a relatively simple analytical function to model the energy spec-
trum of a medical linear accelerator:
denergy (E) = Nenergy E
l exp(−bE) , Emin ≤ E ≤ Emax , (2.8)
where Nenergy is a normalisation factor. To determine the free parameters l and b, a set of
monoenergetic PDD was calculated for a 100×100mm2-field using the MC method. The cal-
culated monoenergetic PDD were superimposed using (2.8) and fitted to a measured PDD.
Monoenergetic PDDs were calculated for energies from 0.5MeV to 7MeV, in steps of 0.5MeV.
In the MC simulations, the source was modelled by a point source, since the real source size
was not yet determined. The direction of primary photons was sampled from the measured
relative angular distribution. Fitting was performed with MATLAB R© lsqcurvefit method (non-
linear curve-fitting in least-squares sense using a trust-region-reflective algorithm). The first 4
millimetres of the PDD were not included in the fit because measurement errors are possibly
not negligible here.
2.A.1.5 Source size
At last, the source size was assessed. The planar source distribution is given by a two-
dimensional Gaussian perpendicular to the forward direction (negative z-direction):
dplanar (x, y) = Nplanar exp
(
− x
2
2σ2x
− y
2
2σ2y
)
(2.9)
with a normalisation factor Nplanar and the standard deviations σx and σy. The latter were
obtained by fitting the penumbra regions of lateral dose profiles calculated in water by means
of MC simulations to those of the measured profiles. The shape of the beam penumbra is
mainly influenced by the size of the photon source. The standard deviations σx and σy could be
restricted to a maximum of 3mm before starting MC simulations. Values above are not expected
in a medical linac. Lateral in-plane (y-directions) and cross-plane (x-direction) profiles were
calculated for quadratic fields of different size (side lengths between 20 and 200mm) and in
different depths in water (15, 50, 100 and 200mm). Profiles were assessed for various σx and σy
and were compared to measured dose profiles. In this manner, the standard deviations giving
the best agreement in the penumbra regions were determined.
2.A.1.6 Validation of source model
For validation, we performed MC simulations including the developed source model and com-
pared the results to the experimental data. Simulations were performed with 950mm SSD
and with quadratic fields of side length 20mm, 50mm and 100mm. Spatial dose distribution,
calculated within the water phantom, was scaled relative to the dose in the field center in
50mm depth. Lateral in-plane and cross-plane dose profiles as well as PDD were compared to
measured profiles scaled in the same way.
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2.A.2 Results
2.A.2.1 Source model
Figure 2.15 shows on the left the relative measured dose profile assumed to be proportional to
the primary photon fluence and on the right the angular distribution deduced following (2.6)
and (2.7). The angular distribution interpolated to a finer θ-grid (grey) was used in the final
source model. The fitting of the calculated monoenergetic PDD to the measured PDD, using
(2.8), resulted in the model parameters l= -1.1517 and b=0.0077MeV−1. The final energy
distribution of the source photons is shown in figure 2.6(b). The standard deviations of the
planar position distribution 2.9 were assigned to σx=σy =0.45 mm.
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Figure 2.15: Left: measured diagonal dose profile (maximum set to one). Right: unnormal-
ized deduced angular distribution for primary photons which is interpolated to a finer grid
(grey).
2.A.2.2 Validation of source model
In figure 2.16, calculated lateral dose profiles and PDD are shown in comparison with the ex-
perimental data. Here, profiles are shown for 50 and 100mm depth in water, but in general,
agreement was similar in 15 and 200mm depth. The relatively good agreement between calcu-
lated and measured dose profiles validates the developed source model. An improved and more
complex source model could potentially reduce the small differences observed at the edges of
the lateral profiles.
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Figure 2.16: MC simulations vs. measurements: Comparison of lateral dose profiles and of
PDD (below right) in water for three different field size: 2×2 cm2, 5×5 cm2, 10×10 cm2. For
each field size, calculated and measured dose profiles were scaled relative to the dose in the
field center in 50 mm depth.
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2.B Details: 2D-bMLC Design
2.B.1 Dimensions of absorber modules
The design of the 2D-bMLC is explained in 2.3.1. In figure 2.1 the principal design and func-
tionality of an absorber channel is shown, and figure 2.3 illustrates how the 900 channels are
arranged side by side in a tessellated pattern on a spherical shell segment. In this section, we
explain how to exactly calculate the dimensions of the channel absorbers.
The indexing of the 2D-bMLC channels is explained in 2.3.2. Here, the two indices correspond-
ing to the column and row indices in 2.3.2 are denoted ix and iy:
ix = 1, 2, 3, ..., 30 (2.10)
iy = 1, 2, 3, ..., 30 (2.11)
In figure 2.18, a closed absorber channel is shown. The three absorbers are denoted A, B and C
respectively. In the following, we give the equations, which can be used to compute the vertexes
of the absorbers for each channel, thus for each 2-tuple (ix, iy). The coordinate system used for
the calculations is shown in figure 2.17. Its origin lies at the position of the linac source. The
directions X, Y and Z’ corresponds to the directions X, Y and -Z of the GANTRY system (see
figure 2.5(b)).
The vertexes of the absorbers lie on spherical shells around the linac source. The radii of the
spheres are given in figure 2.17(a).
A1 = 190mm
A2 = 230mm
B1 = 240mm
B2 = 320mm
C1 = 330mm
C2 = 370mm
Source
z’
               Radius
x
(a) The vertexes of the absorber elements lie on spherical
shells around the linac source. Two radii are given for the
absorber elements A, B and C respectively.
X
Y
Z'
Source
Collimator
Isocentric plane
(b) Coordinate system
Figure 2.17: Radii and coordinate system used in the calculations of the absorber vertexes.
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Further, we define the base length ∆b and the base angle αb:
∆b = 5mm (2.12)
αb = arctan
(
∆b
SAD
)
(2.13)
with the source-axis distance SAD = 800mm. ∆b is half the requested side length of the
projection of a channel onto the isocentric plane. We assign a set of angles to channel (ix,iy):
α−ix = (2 · ix− 32)αb (2.14)
αoix = (2 · ix− 31)αb (2.15)
α+ix = (2 · ix− 30)αb (2.16)
and
α−iy = arctan
(
(iy − 16) ∆b
SAD
)
(2.17)
α+iy = arctan
(
(iy − 15) ∆b
SAD
)
(2.18)
On the following page, we give the equations for the vertexes of the absorbers placed within
the closed channel (ix,iy). In principle, the equations correspond to rotations around the X-
and Y-axis subsequently applied to a vector (0, 0, R), where R is one of the radii given in figure
2.17(a). The angles of rotation are given by the equations 2.14 to 2.18. As an example, we give
the detailed calculation of the vertex a−−1 for channel (ix,iy):
a−−1 =
 cos (α−ix) 0 sin (α−ix)0 1 0
− sin (α−ix) 0 cos (α−ix)
 ·
1 0 00 cos (α−iy) sin (α−iy)
0 − sin (α−iy) cos (α−iy)
 ·
 00
A1

= A1 ·
sin (α−ix) cos (α−iy)sin (α−iy)
cos (α−ix) cos (α
−
iy)
 (2.19)
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Vertexes of the absorbers A, B and C in the closed channel (ix,iy)
Absorber A:
a−−1 = A1
sin (α−ix) cos (α−iy)sin (α−iy)
cos (α−ix) cos (α
−
iy)
 ao−1 = A1
sin (αoix) cos (α−iy)sin (α−iy)
cos (αoix) cos (α
−
iy)
 a−+1 = A1
sin (α−ix) cos (α+iy)sin (α+iy)
cos (α−ix) cos (α
+
iy)
 ao+1 = A1
sin (αoix) cos (α+iy)sin (α+iy)
cos (αoix) cos (α
+
iy)
 (2.20)
a−−2 = A2
sin (α−ix) cos (α−iy)sin (α−iy)
cos (α−ix) cos (α
−
iy)
 ao−2 = A2
sin (αoix) cos (α−iy)sin (α−iy)
cos (αoix) cos (α
−
iy)
 a−+2 = A2
sin (α−ix) cos (α+iy)sin (α+iy)
cos (α−ix) cos (α
+
iy)
 ao+2 = A2
sin (αoix) cos (α+iy)sin (α+iy)
cos (αoix) cos (α
+
iy)
 (2.21)
Absorber B:
bo−1 = B1
sin (αoix) cos (α−iy)sin (α−iy)
cos (αoix) cos (α
−
iy)
 b+−1 = B1
sin (α+ix) cos (α−iy)sin (α−iy)
cos (α+ix) cos (α
−
iy)
 bo+1 = B1
sin (αoix) cos (α+iy)sin (α+iy)
cos (αoix) cos (α
+
iy)
 b++1 = B1
sin (α+ix) cos (α+iy)sin (α+iy)
cos (α+ix) cos (α
+
iy)
 (2.22)
bo−2 = B2
sin (αoix) cos (α−iy)sin (α−iy)
cos (αoix) cos (α
−
iy)
 b+−2 = B2
sin (α+ix) cos (α−iy)sin (α−iy)
cos (α+ix) cos (α
−
iy)
 bo+2 = B2
sin (αoix) cos (α+iy)sin (α+iy)
cos (αoix) cos (α
+
iy)
 b++2 = B2
sin (α+ix) cos (α+iy)sin (α+iy)
cos (α+ix) cos (α
+
iy)
 (2.23)
Absorber C:
c−−1 = C1
sin (α−ix) cos (α−iy)sin (α−iy)
cos (α−ix) cos (α
−
iy)
 co−1 = C1
sin (αoix) cos (α−iy)sin (α−iy)
cos (αoix) cos (α
−
iy)
 c−+1 = C1
sin (α−ix) cos (α+iy)sin (α+iy)
cos (α−ix) cos (α
+
iy)
 co+1 = C1
sin (αoix) cos (α+iy)sin (α+iy)
cos (αoix) cos (α
+
iy)
 (2.24)
c−−2 = C2
sin (α−ix) cos (α−iy)sin (α−iy)
cos (α−ix) cos (α
−
iy)
 co−2 = C2
sin (αoix) cos (α−iy)sin (α−iy)
cos (αoix) cos (α
−
iy)
 c−+2 = C2
sin (α−ix) cos (α+iy)sin (α+iy)
cos (α−ix) cos (α
+
iy)
 co+2 = C2
sin (αoix) cos (α+iy)sin (α+iy)
cos (αoix) cos (α
+
iy)
 (2.25)
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2.B.2 Theoretical projection onto the isocentric plane
The theoretical projection of a channel opening onto the isocentric plane can be computed in
two steps: First, the vertexes of the channel opening at radius C2, where the radiation exits
the channel, are assessed. Secondly, a projection of the vertexes onto the isocentric plane is
calculated.
Figure 2.19: Vertexes of the channel opening at the lower edge of the collimator and of the
projection of the opening onto the isocentric line.
The vertexes of the opening at C2 as well as those of its theoretical projection onto the isocentric
plane are defined in figure 2.19. The vertixes are similar to those of absorber B in figure 2.18
but at radius C2. Together with equations 2.10 to 2.18, the equations for the vertexes of the
opening of channel (ix,iy) at radius C2 are given by:
vo− = C2
sin (αoix) cos (α−iy)sin (α−iy)
cos (αoix) cos (α
−
iy)
 v+− = C2
sin (α+ix) cos (α−iy)sin (α−iy)
cos (α+ix) cos (α
−
iy)

vo+ = C2
sin (αoix) cos (α+iy)sin (α+iy)
cos (αoix) cos (α
+
iy)
 v++ = C2
sin (α+ix) cos (α+iy)sin (α+iy)
cos (α+ix) cos (α
+
iy)
 (2.26)
The vertexes of the projection of the opening onto the isocentric plane can then be obtained
using the intercept theorem. For the first vertex we can calculate:
wo− =
SAD
vo−(z)
· vo− = SAD
cos (αoix) cos (α
−
iy)
·
sin (αoix) cos (α−iy)sin (α−iy)
cos (αoix) cos (α
−
iy)
 = SAD ·
 tan (αoix)tan (α−iy)/ cos (αoix)
1

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with SAD = 800mm and with the z-coordinate vo−(z) of vertex v
o−. For the collimator presented
in this work, the rotation angles are all below 11◦ and the division by the cosine is unproblematic.
Here are the final equations for all four vertexes:
wo− = SAD ·
 tan (αoix)tan (α−iy)/ cos (αoix)
1
 w+− = SAD ·
 tan (α+ix)tan (α−iy)/ cos (α+ix)
1

wo+ = SAD ·
 tan (αoix)tan (α+iy)/ cos (αoix)
1
 w++ = SAD ·
 tan (α+ix)tan (α+iy)/ cos (α+ix)
1
 (2.27)
The theoretical width of the beam spots and the deviation maps presented in section 2.B.2 were
assessed using these equations.
The projection to any plane downstream the collimator and parallel to the isocentric plane can
be assessed, if SAD is replaced by the distance of the respective plane to the source along the
central axis (Z’-axis in figure 2.17(b)).
2.B.3 2D-bMLC design variations
2.B.3.1 2D-bMLC pattern
In the 2D-bMLC model presented in 2.3.1, the channels arranged side by side in the 2D matrix
have all the same alignment concerning the position of the fixed absorber modules. In principle,
the mirrored alignment could also be an option. In figure 2.20 the two possible alignments are
shown in a channel’s cross section in the x-z-plane. If a channel is open, all three blocks are on
the same side: on one side for alignment I and on the other side for alignment J.
I J
Figure 2.20: The two possible alignments of a 2D-bMLC channel labelled I and J respec-
tively. The cross section of a channel in the x-z-plane is shown (see also figure 2.1 and 2.18).
Variations of our 2D-bMLC pattern with equally aligned channels are imaginable. In figure
2.21(b) and 2.21(c) we propose two possible variations of the pattern, which could also be used
in rotational treatments, as they are described in chapter 3. The channel alignment is only
shown for one row of elements (see section 2.3.2 for the definition of rows and columns). We
assume that all channels of one column are of same alignment. Different channel alignments in
one column would not make sense for our treatment concept with only one gantry rotation and
fixed collimator angle. The channel openings of one column all abut in our design. A varied
alignment of the channels would basically make no difference for the treatments, except a further
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reduction of primary radiation efficiency and the introduction of additional tongue-and-groove
effects, where neighbouring channels would not abut.
Finally, we have chosen the pattern with identically aligned channels, because larger gaps
between the channel beams should be avoided, and because it is the most regular pattern.
We suppose that a regular design is easier to establish in practise.
(a) · · · IIIIIIII · · · (b) · · · IIIIJJJJ · · · (c) · · · IJIJIJIJ · · ·
Figure 2.21: (a) Pattern of channel openings of the presented 2D-bMLC model. (b& c) two
alternative designs. See figure 2.20 for the definition of the channel alignments I and J.
2.B.3.2 Collimator tilts
Another feature that could be implemented in a treatment machine equipped with a 2D-bMLC
is a small tilt of the collimator as illustrated in figure 2.22. The tilt corresponds to a rotation
of the collimator around the fixed photon source, so that all the absorber channels are still full
focusing. As a consequence of a tilt, the 2D-bMLC beams are quasi shifted laterally.
In principle, tilts around both axes, the x- and y-axis in figure 2.5(b), are possible. In figure
2.23, we illustrate two useful shifts around the y-axis. In figure 2.23(a), our untilted 2D-bMLC
design is shown. The beam of the most central channel just passes the central axis of the
machine. A tilt of half the base angle αb given in equation 2.13 would assure, that the beam
centres the central axis (figure 2.23(b)). A tilt of full αb would allow for a shift of the striped
2D-bMLC field, so that field stripes and gaps would quasi be exchanged 2.23(c).
Although we did not include collimator tilts in our treatment strategy presented in chapter
3, they could become especially useful in treatments with several rotations. For example, two
rotations could be performed with different collimator tilts subsequently. In the study presented
in chapter 5.2 a tilt angle of -αb2 was used for the calculation of the primary radiation efficiency
of the 2D-bMLC.
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Isocenter Isocenter
collimator
axis
collimator
axis
Figure 2.22: Tilt of the collimator around the linac source. The channels remain full focusing.
Tilts around both the x- and y-axis in figure 2.5(b) are possible.
(a) tilt 0 (b) tilt αb
2
(c) tilt αb
Figure 2.23: Different tilts of the 2D-bMLC around the y-axis in figure 2.5(b). The tilts are
specified as fractions of the base angle αb given in equation 2.13, which spans half a collimator
channel. The tilt angle of 0 corresponds to our design as presented in 2.3.1.
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Treatment Planning for Fast
Rotational IMRT with the 2D-bMLC
3.1 Overview
We developed a treatment planning system (TPS) for rotational 2D-bMLC treatments with a
flattening filter free medical linac, a new optimization method and a Monte Carlo framework
for exact calculation of the dose (sections 3.3.2–3.3.3).
A planning comparison was performed for five different clinical indications. The methods of the
planning study are described in section 3.3.4, the results are presented in 3.4. With a maximum
dose rate of 2000 MU/min delivery times of the 2D-bMLC treatments were estimated between
20 and 25 s. For two cases, additional plans were calculated for a max dose rate of 4000 MU/min
and delivery times of 10 and 11 s. Clinically approved dose distribution of a Tomotherapy
system were used as Gold Standard. The 2D-bMLC plans fulfilled the clinical goals. Dosimetric
parameters were comparable to those of the Tomotherapy plans. The results of the study showed
that the 2D-bMLC concept is in principal adequate for rotational radiotherapy treatments with
potential delivery times considerably below those of IMRT techniques applied in the clinics
today.
Publication
Parts of this chapter have been presented at international conferences, at the 2nd ESTRO
Forum in Geneva, Switzerland, April 2013 (Altenstein et al., 2013a) and at the AAPM 55th
Annual Meeting in Indianapolis, USA, August 2013 (Altenstein et al., 2013b).
3.2 Introduction
As discussed in detail in chapter 2, the 2D-bMLC radiation fields are characterised by a striped
pattern. The spatial fractionation into stripes renders the concept impractical for treatments
with only a few beam directions. Dose distributions in the patient would be highly inhomo-
geneous. However, in rotational treatments limitations due to the field fractionation could
eventually be overcome.
The planning framework is composed of two independent tools, a treatment planning system
(TPS) for inverse plan optimisation and a tool for plan re-computation with a time-dependent
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MC method. The TPS uses a pencil-beam (PB) dose algorithm and the gantry rotation is
approximated by fixed beam directions. In contrast, the time-dependent MC simulations in-
clude a realistic model of the collimator absorber and gantry dynamic. Also, leakage dose and
tongue-and-groove effects are modelled in a more appropriate way. (Shin et al., 2012) proposed
a very efficient ‘time feature’ method for the handling of time-dependent quantities in MC sim-
ulations of radiotherapy applications. The method was applied to the 2D-bMLC treatments
and implemented in the MC tool.
Typical delivery times for IMRT fractions are today in the range of several minutes. For many
cases delivery times of the newer intensity-modulated arc therapy techniques (Otto, 2008b;
Ulrich et al., 2007b; Wang et al., 2008; Yu, 1995) are below those of conventional fixed-gantry
IMRT (Holt et al., 2013; Van Gestel et al., 2013). Delivery times could potentially be reduced
with the FFF mode of medical linacs, which is characterised by significantly increased dose
rates. (Georg et al., 2011; Mancosu et al., 2012; Salter et al., 2011; Spruijt et al., 2013). With
the possibility to perform very quick 2D aperture changes, the 2D-bMLC should bring new
ability to make use of high dose rate beams. In this study, we want to give an estimate of the
minimum time needed for the delivery of an acceptable 2D-bMLC plan.
For the retrospective planning comparison, clinically approved dose distribution of a Tomother-
apy system were used as Gold Standard. The capabilities of the Tomotherapy system to shape
conformal dose distribution has been shown for various oncological situations, including the
most challenging cases in terms of size, complex geometry and sparing of organs at risk (Fior-
ino et al., 2006; Peñgarícano et al., 2005; Sterzing et al., 2008a,b, 2009, 2010a; Wong et al.,
2006). Five different clinical indications were selected for the plan comparison, covering a wide
variety of target sizes and general planning complexity.
3.3 Methods
3.3.1 Models of the 2D-bMLC and the treatment machine
Within the Treatment planning system (TPS) and the 4D Monte Carlo tool, we modelled a
treatment machine, which was similar to that described in section 2.3.3.1. Here, we review
shortly the general specifications of the machine: A flattening-filter-free (FFF) 7MV linac
source was modelled within the treatment machine. The source-axis distance was set to 800
mm. The modelled 2D-bMLC consisted of 30 by 30 absorber channels, resulting in a maximum
field size of 300 by 300 mm2 in the isocentric plan. The side lengths of the quasi-rectangular
beams exiting a 2D-bMLC channel are approximately 5 mm and 10 mm in the isocentric plane.
Between the source and the collimator, the radiation can be pre-collimated to rectangular fields
of adjustable side lengths.
In figure 3.1, an exemplary 2D-bMLC field is shown to illustrate the characteristics of the
radiation fields delivered with the modelled treatment machine. The fields are characterised
by a striped pattern. However, the concept allows independent control of each channel. Apart
from the time needed to open or close the channels, no leaf constraints restrict the choice of
apertures.
Some new features were added to the treatment machine model in order to adapt it to rotational
IMRT treatments. The source, the pre-collimator and the 2D-bMLC form together the gantry,
which can rotate around the isocenter (see figure 3.2). The direction of movement is thereby
perpendicular to the characteristic stripes of the radiation fields. At any gantry angle, the
central ray of the radiation is pointing to the isocenter. The dose rate of the machine is tunable
between a minimum and a maximum value defined in the planning process described below in
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Example field
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(maximum set to 1)
Figure 3.1: The 2D-bMLC fields are characterised by a striped pattern. Therefor, the concept
allows independent control of each channel.
section 3.3.2. No constraints are considered for the speed of dose rate changes, i.e. the dose
rate can be changed instantaneously between two values within the given range.
ΩG
arc
segment k
gantry
patient
source
pre-collimator
2D-bMLC
gantry
Figure 3.2: Setup for rotational 2D-bMLC treatments. The virtual linac source, the pre-
collimator and the 2D-bMLC form together the gantry, which rotates around the isocenter.
For treatment planning the gantry rotation is divided into arc segments of equal size with
respect to gantry angle.
3.3.2 Treatment planning system (TPS)
3.3.2.1 2D-bMLC treatments and their parameters
A 2D-bMLC treatment fraction is delivered with constant gantry speed within one gantry
rotation. The TPS calculates a plan for a user specified fractional treatment time TF. The
rotation has to be finished within this time, and the angular speed of the gantry is given by
Ω˙G =
2pi
TF
. (3.1)
The full rotation is subdivided into Nseg segments of equal size with respect to gantry angle.
In the current version three options are available for Nseg: 48, 72 or 96. The subdivision of the
rotation into arc segments is illustrated in figure 3.2. We denote the set of segments by K and
the set of 2D-bMLC channels by J. Further, τjk is the opening time of bixel jk, which refers to
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channel j∈J in segment k∈K. τjk is constrained as follows:
τjk = 0 or τmin ≤ τjk ≤ τmax . (3.2)
Times between 0 and τmin would not be practical, because a certain time is needed for the
mechanics to open and close a channel. The maximum opening time per segment τmax is given
by
τmax =
TF
Nseg
. (3.3)
With τmax ≥ τmin and equation 3.3, we establish the following constraint for TF:
TF ≥ Nseg · τmin (3.4)
A dose rate D˙k is assigned to each segment k. D˙k is limited by the machine specific minimum
dose rate D˙min and maximum dose rate D˙max:
D˙min ≤ D˙k ≤ D˙max (3.5)
with
0 ≤ D˙min ≤ D˙max . (3.6)
3.3.2.2 Dose calculation
The patient geometry is discretised into a set of voxels I. The dose deposition coefficient Dijk
gives the dose deposited in voxel i ∈ I by unit intensity of bixel jk. We define the intensity of
bixel jk as the the product of opening time τjk and dose rate D˙k. The total dose in voxel i,
denoted as di, can then be expressed by
di =
∑
k∈K
∑
j∈J
DijkτjkD˙k . (3.7)
The coefficients Dijk are calculated with the treatment planning tool KonRadXP (Nill, 2001),
which uses a pencil beam dose calculation algorithm and a macro pencil beam based on Monte
Carlo calculated input data (more details are given in section 3.A). The arc segments were
approximated by fixed beam directions, centrally aligned with the respective segments.
3.3.2.3 Objective function
Within the TPS, a standard least square objective function was used (Bortfeld et al., 1990;
Holmes et al., 1991). The voxels i ∈ I are unequivocally assigned to volumes of interest (VOIs),
either to target volumes or to organs at risk (OARs). Let V be a set of VOIs and Iv be the set of
voxels in volume v ∈ V . Each target volume is contained once in V. OARs can be represented
manifold, each instance treated as an independent VOI. In doing so, the user can specify several
(soft) dose constraints for an OAR, e.g. one constraint to minimise the dose to the OAR in
general and a second constraint to penalise hot spots. The objective function for volume v is
defined as
Fv =
1
Nv
·
∑
i∈Iv
p+v ·
[
di −D+v
]2
+
+ p−v ·
[
D−v − di
]2
+
(3.8)
with
[·]+ = max{0, ·} . (3.9)
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Nv is the number of voxels in set Iv. The user specifies the (soft) maximum and minimum dose
constraints, D+v and D−v respectively, for all VOIs v ∈ V . p+v and p−v are the positive penalty
values for overdosage and underdosage of VOI v respectively. By definition p−v is 0 for all OARs,
because minimum dose constraints for OARs are in general not useful. The parameters D+v ,
D−v , p+v and p−v have to be defined prior to plan optimisation.
The full objective function F is given by the sum over all Fv:
F =
∑
v∈V
Fv . (3.10)
3.3.2.4 Optimisation framework
Preliminary steps:
↓ pre-optimise
↓ set bixel states
↓ calculate gjk
↓ adapt bixel states
optimise τjk and D˙k
calculate gjk
test if
gjk≥0
∀jk
adapt bixel states
finish
yes
no
Figure 3.3: Scheme of the optimisation framework. The main optimisation loop is highlighted
in grey. A detailed description of the different steps can be found in the text in section 3.3.2.4.
Dose rates D˙k and channel opening times τjk are optimised inversely for a 2D-bMLC plan. The
optimisation problem is formulated as follows:
minimise F subject to 3.2 and 3.5 (3.11)
The optimisation strategy, we use to solve this problem, is shown schematically in figure 3.3.
Before going into details, we define the bixel states ’open’ and ’closed’. If bixel jk is closed, τjk
is 0, if it is open, τjk is between τmin and τmax. The following rule is defined to switch a bixel
state:
Rule 1. Bixel state switch: The bixel is set from its current state to the other, that is from
open to closed or vice versa. τjk is set to 0 if bixel jk is closed; If its state is switched to open,
τjk is set from 0 to τmin.
We define gjk as the change in the objective function implicated by the state switch of bixel jk,
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while holding all other parameters fixed:
gjk = F (bixel jk switched)− F . (3.12)
We call gjk the price of the state switch of bixel jk. If a price gjk is negative, the state switch
of the respective bixel is beneficial in terms of decreasing the objective function F. We define
a second rule to select, which bixels should be switched after calculation of gjk. The idea is
to pre-select all bixels with a negative price gjk. We then start by switching the bixel, which
brings the maximal benefit, hence the one with the lowest switch price (highest negative value).
In general, a bixel state switch can change all gjk. Therefore, before the switch of another bixel,
the negativity of its switch prize has to be re-approved.
Rule 2. Adapt bixel states: First, select the bixels with negative prices gjk. Order the bixels
according to the values of gjk, starting with the smallest value (highest negativity). Then, loop
over the pre-selected bixels following the established order. In each iteration of the loop, re-
assess the respective switch price considering all state switches already performed. Switch the
bixel state if its switch price remains negative.
As shown in figure 3.3, the inverse optimisation of a 2D-bMLC treatment plan is composed of
preliminary steps and the main optimisation loop.
Preliminary steps Before starting the main loop, the following modified problem is solved
with a limited-memory algorithm for bound constrained optimisation (L-BFGS-B) (Byrd et al.,
1995; Morales and Nocedal, 2011; Zhu et al., 1997):
minimise F subject to 0 ≤τjk≤τmax and D˙k=D˙max (3.13)
The optimisation is terminated if changes of the objective function stay below a predefined
value. Evaluating the final τjk of the preliminary optimisation, the bixel states are set as
follows:
if τjk<τmin/2 : close bixel jk (3.14)
if τjk≥τmin/2 : open bixel jk (3.15)
Subsequently, gjk are calculated and the bixel states are adapted following rule 2.
Main optimisation loop The main optimisation loop is started right after the preliminary
optimisation. The loop is divided into four steps:
1. Optimise the variables D˙k and τjk with fixed bixel states. Therefore, minimise F subject
to 3.5 and to
τmin ≤ τjk ≤ τmax for open bixels (3.16)
τjk = 0 for closed bixels (3.17)
Again a L-BFGS-B algorithm is used.
2. Calculate gjk.
3. Test if all gjk are positive. If so, terminate the optimisation.
4. Adapt bixel states following rule 2.
The main loop is repeated until its termination in step 3.
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3.3.3 4D Monte Carlo tool
3.3.3.1 Time feature formalism
For the time-dependant MC simulations, we make use of the Time Feature formalism, as it
was presented by Shin et al. (2012) and by Perl et al. (2012). A function of time, called ‘Time
Feature’, is associated to a simulation quantity, which varies over time. A Time Feature (TF)
assigns a well-specified value to any specific time within the time range of the simulation.
In the Time Feature formalism, a time-dependant MC simulation - also called a 4D MC simu-
lation - can run in two different modes: In the sequential mode, the time is sampled in regular,
even intervals, from start time to end time, and one or more histories are simulated for each time
step. In random mode, time values are sampled randomly between the start and the end time.
For each history, a new random time is sampled. In both modes, TF values are computed,
once a new time value has been sampled, and the corresponding time-dependant simulation
quantities are updated. If necessary, also the simulation geometry has to be updated.
3.3.3.2 Implementation of the TF formalism
The 4D MC tool was implemented with Geant4.9.5 (Agostinelli et al., 2003). The 2D-bMLC
therapy is simulated in random mode. In random mode geometry changes can occur after
each simulated history. If the geometry updates are not performed efficiently, this can lead to
exhaustively long computation times. Therefore, all moving objects have been implemented
as so called parametrised volumes (Geant4 Collaboration, 2011). This volume class available
in the Geant4 tool kit allows to define parametrisation functions, which calculate geometrical
parameters of the respective volumes such as its position and rotation. There are different
methods to implement movements in Geant4, but with parametrised volumes the geometry
update during the simulation is managed very efficiently and fast.
Over the course of a 2D-bMLC treatment the dose rate can change multiple times. To account
for these changes, we do not sample the time from an uniform distribution but from a probability
density distribution f(t), which corresponds to the dose rate over time normalised over the full
treatment time.
The 4D MC tool can handle the following quantities as TFs: Channel openings, gantry angle,
collimator angle, collimator tilts and target point coordinates. Actually, in the simulations
performed for this study, only the gantry angle and the channel openings varied over time and
were defined as TFs:
ΩG(t): gantry angle
Oj(t): relative opening of channel j (for all j ∈ J)
3.3.3.3 Conversion of a treatment plan into a set of TFs
The TPS calculates the dose rates D˙k and the bixel opening times τjk. The conversion from
these parameters to a deliverable MC plan, hence to a set of TFs ΩG and Oj , is explained here.
A MATLAB program has been written for the conversion.
As discussed in 3.3.2.1, the gantry speed is constant over the course of the 2D-bMLC treatment.
With the angular speed of the gantry, given in 3.1, the TF of the gantry angle can be written
as a linear function:
ΩG (t) = Ω˙G t =
2pi
TF
t (3.18)
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Oj
t
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arc segment k
opening time τjk
(a) Oj(t) for arc segment k
∆t
∆t ≥ τshift
∆t
∆t < τshift
(b) Rules for the processing of Oj(t)
Figure 3.4: The TF Oj(t) describes the relative opening of channel j over time. (a) Oj is
generated from the opening times τjk given by the TPS. Opening and closing of the channel
is modelled with constant speed corresponding to linear ramps in Oj . (b) If the opening times
of subsequent arc segments are together too long to allow closing and re-opening in between
the two segments, the channel stays open.
As shown in figure 2.18, 2D-bMLC channels are opened and closed by the shift of a tungsten
block between two positions. For further details we refer to section 2.3.1. In the 4D MC tool,
the shift is modelled with constant speed. τshift is the time needed for the mechanical shift. For
the plans presented in this paper, τshift was fixed to 100 ms.
TF Oj(t) describes the relative opening of channel j. Oj(t) can vary between 0 and one, whereas
the values 0 and one correspond to a fully closed and a fully opened channel respectively. Oj is
generated from the opening times τjk given by the TPS for all arc segments k ∈ K. If τjk=0,
the channel does not open in arc segment k, and consequently Oj remains 0 while the gantry
passes this segment. In figure 3.4(a), we show Oj for arc segment k if τjk≥τmin. Linear ramps
describe the shift of the central block. The ramps can extend into neighbouring arc segments
if τjk is close to τmax. The time domain, where Oj 6=0, is centred in the angular segment k.
In principal, a channel can open and close in all segments. But if the opening times of subsequent
arc segments are together too long to allow the full mechanical shifts in between the two
segments, the channel stays open. Figure 3.4(b) illustrates the corresponding rules for the
processing of TF Oj .
3.3.3.4 Further details about the MC simulations
A Geant4 standard electromagnetic physics list with best advanced electromagnetic options was
used1.
The MC simulations are split up in two separate parts. In a first part the gantry rotation and
the transport of the source photons through the collimator are simulated. All particles exiting
the collimator are scored in a phase space file. This simulation is made time-dependant with
the TF formalism as described above. In a second simulation the particle transport through
the time-independent patient geometry is simulated, and the spatial dose deposition is scored.
Thereby, each phase space particle of the first simulation, is reused 10 times, but each time
with different random numbers. The patient geometry is modelled as a set of voxels of water
with different electron densities (Ma and Li, 2011). The electron densities are acquired through
conversion from the Hounsfield units (HU) of computed tomography (CT) scans. CT data sets
are imported in DICOM format (Aso et al., 2007). The conversion follows a mapping based on
phantom measurements. Below a cut-off value of -920 HU the voxels are modelled as air voxels.
1The physics list was similar to that which is loaded with the physics list constructor emstandard_opt3. The
physics list constructors are developed and maintained by the electromagnetic working group of the Geant4
collaboration. Further information can be found on http://geant4.web.cern.ch/geant4/collaboration/
working_groups/electromagnetic/physlist.shtml.
60
3.3. Methods
Table 3.1: Dose prescriptions and planning parameters for the studied cases. For cases 2 to 5,
a multi-focal simultaneous integrated boost concept was applied. (The TPS parameter D˙min
was fixed to 500 MU/min for all plans.)
Case Dose prescription TPS param. MC param.
PTV volume D50% Fx Nseg D˙max TF pre-coll. field
[ml] [Gy] [MU/min] [s] size [mm2]
1. Prost. PT 74 80.0 40 48 2000 20, 40 160x160only 48 4000 10
2. Prost. boost PT 74 76.5 34 72 2000 20, 40 170x280boost LDP 1040 51.0 34 72 4000 11
3. Oral boost PT 314 70.4 32
300x240cavity boost LN 18 70.4 32 72 2000 25
LDP 1083 57.6 32
4. Naso- boost PT 220 70.4 32
300x260pharynx boosts LN 231&101 70.4 32 72 2000 25
LDP 1324 57.6 32
5. Anal boost PT 442 58.8 28
310x310boosts LN 122&10 58.8 28 96 2000 25
LDP 3329 50.4 28
PTV: planning target volume, PT: primary tumour, LN: lymph node, LDP: Lymphatic drainage pathways, D50%: median dose, Fx:
number of fractions
The resolution of the voxel grid, in which also the dose scoring is performed, corresponds to the
pixel size and the slice thickness of the CT images respectively.
MC simulations were performed in multiple parallel jobs. As a measure for statistical uncer-
tainty of the final MC dose distribution, the fractional uncertainty in the average dose for voxels
with dose values greater than 50% of the maximum dose, F d>0.5dmax , was calculated (Chetty
et al., 2007). For all cases presented in this chapter, F d>0.5dmax was about 1%.
3.3.4 Plan comparison study
For four patients and five clinical indications, we performed a retrospective planning comparison
using clinically approved dose distribution of a Tomotherapy system as Gold Standard.
Patients and radiotherapy planning Tumour sites were prostate (cases 1 and 2), oral cav-
ity (3), nasopharynx (4) and anus (5). No modifications were made to the previously accepted
delineation of the target volumes and organs at risk (OAR). Planning target volumes (PTV) and
dose prescriptions are specified in the left column of table 3.1. In case 1, dose was prescribed to
the primary tumour PTV. For cases 2 to 5, a multi-focal simultaneous integrated boost concept
was applied, with boosts to the primary tumour and the involved lymph nodes (Sterzing et al.,
2010b). Lower doses were prescribed to the lymphatic drainage pathways (LDP). Case 1 and
2 are prescription variants for the same prostate patient with different hypothetical tumour
staging. Planning was based upon CT scans with pixel size 1.95mm and slice distance 2mm
(cases 1 and 2) or 3mm (cases 3-5).
Tomotherapy planning Tomotherapy (HT) planning was performed with the Tomotherapy
planning station version 4.0. A field width of 2.5 cm in regular mode and a pitch of 0.43 was
chosen. For more information about HT treatments and planning, we refer to (Jeraj et al.,
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2004; Mackie et al., 1999; Welsh et al., 2002).
2D-bMLC plans 2D-bMLC plans were optimised for a given set of TPS parameters Nseg,
D˙max and TF (see section 3.3.2.1). The penalty values in equation 3.8 were manually adjusted
to obtain the best plan. The best plan was defined as the plan, which fulfilled the clinical
constraints for the PTVs and minimises the dose to the most critical OARs. The plans presented
in this paper are summarised in the middle column of table 3.1. In the following, the plans
are named by their TF (e.g. plan 20s for case 1). For all cases, plans were generated for a a
maximum machine dose rate D˙max of 2000 MU/min. In addition for case 1 and 2, plans were
optimised for D˙max = 4000 MU/min and reduced TF. (For case 1, the half TF of plan 20s was
used; for case 2, TF was set to the smallest rounded number satisfying inequality 3.4.) For all
plans, the minimum dose rate was fixed to 500 MU/min.
The plans were recomputed with the MC tool. In the MC simulations, the pre-collimator field
(see figure 3.2) was adapted to enclose all channels, which open during the treatment, plus a
margin of one channel width. In the last column of table 3.1, the dimensions of the pre-collimator
fields in the isocentric plane are given. The MC calculated plans were finally rescaled, so that
the median dose received by the primary tumour PTV matches the dose prescription.2
Plan evaluation For plan comparison cumulative dose-volume histograms (DVH) were cal-
culated. Air voxels (HU value below −920) were not considered. For the volumes of interest
(VOI), the near-minimum dose D98% and the near-maximum dose D2% were assessed (ICRU
report 83). D50% is the median dose to a VOI; VXGy is the percentage of a VOI receiving more
than XGy. PTV coverage was evaluated using V95%, i.e. the relative fraction of the PTV cov-
ered by the 95% isodose. The uniformity index (UI) is calculated as the ratio between the dose
received by 5% of the PTV and the dose received by 95% of the PTV (UI = D5%/D95%). The
conformity index (CI) is defined as the ratio between the volume covered by the 95% isodose
and the target volume covered by the 95% isodose (CI= V95%/PTV95%) (Krause et al., 2012;
Pirzkall et al., 2000; Sterzing et al., 2010b).
The normal tissue volume was defined as the patient body minus the target volumes. For
DVH analysis, the normal tissue volume was restricted to the scanned region covering all target
volumes ±5 cm.
3.4 Results
3.4.1 Comparison of TPS and MC calculated plans
In figure 3.6(a), we show DVHs for the plan with TF = 25 s for case 5 (anal cancer) as calculated
by the TPS and by the MC tool. The dose distributions shown as colour maps in figure 3.5 are
from the same plans. The comparison illustrates a general trend, that can also be reported for
the other cases: The target dose uniformity is reduced in the MC calculated plans compared to
the TPS plans. This results in less steeper DVHs for the PTVs. As can be seen in the tables 3.2
and 3.3, maximum doses D2% as well as the target dose uniformity indices (UI) are increased
relatively by up to 3%. Furthermore, the minimum doses D98% are decreased by 1-2% in case
4 and 5. In the tables, we also see, that the mean dose to the normal tissue is increased in the
2In practise, a plan rescaling of several percent can be implemented as follows: To scale the planned doses
down, the dose rates D˙k are reduced uniformly by the respective factor. To scale the doses up, the channel
opening times can be multiplied with the scaling factor. In general, this conditions a reduction of the gantry
speed, and TF is increased by the scaling factor.
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MC calculations, by 0.5Gy for case 1 and by about 1Gy for case 2-5. No relevant differences
in doses to the OARs can be reported.
HT 25s (TPS) 25s (MC)
 
 
CT image
 
 
PTV boost PTV LDP Patient outline
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Figure 3.5: Case 5 (anal cancer): Dose colour maps for HT and 25s as calculated by the TPS
and the MC tool.
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(b) Comparison of different 2D-bMLC plans
Figure 3.6: (a) DVHs of 25s for case 5 as calculated by the TPS and the MC tool. (b) Case
1: DVHs for the MC calculated 2D-bMLC plans and for the HT reference plan. For the PTV,
the 2D-bMLC plans have very similar DVHs and only 20s is shown in comparison to HT.
3.4.2 Comparison of 2D-bMLC plans with different TF
In figure 3.6(b), DVHs for case 1 (prostate only) are shown. Comparing the plans optimised
for a D˙max = 2000MU/min, it can be seen, that dose to the rectum is spared if TF is increased
from 20 to 40 s. However, concerning V50Gy (8% for 40s, 12% for 20s) and V70Gy (4% for both
plans) the differences were seen as not clinically significant. The PTV coverage index V95% is
0.92 for 40s and 0.91 for 20s. Table 3.2(a)) shows all DVH parameters calculated for plan 20s
and 10s. For 10s, i.e. the plan calculated for D˙max = 4000MU/min, V95% is 0.89 (TPS 0.91).
Relative differences in D2% and D98% between the two plans are below 1%, and no differences
can be observed concerning dose to the OARs and the normal tissue.
Very similar results can be reported for the 2D-bMLC plans calculated for case 2, in which an
integrated boost concept was applied. Here, doses to rectum and bladder can be reduced by
increasing TF from 20 to 40 s, but again not in a clinically relevant amount. DVH parameters
calculated for plan 20s and 11s are reported in table 3.2(b).
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3.4.3 Comparison with HT
In table 3.2 and 3.3, DVH parameters of the 2D-bMLC plans and of the HT reference plans
can be compared. Here, we want to summarise major differences, which are highlighted in the
tables (relative differences are given in %): For case 1, The HT plan has better PTV coverage
(∆V95% = 2 − 6%). In case 2, Dose coverage of the boost PTVs is better for the 2D-bMLC
plans (∆V95% ∼ 4%), whereas coverage of the LDP PTV is better for HT (∆V95% 2− 4%). In
some cases, the minimum dose to the PTV was slightly higher with HT compared to the MC
calculated 2D-bMLC plans: Maximum differences are observed in case 5 (∆D98% = 1.2Gy for
the boost PTVs) and in case 1 ( ∆D98% = 1.3Gy between HT and 10s).
For all cases the 2D-bMLC plans have better target dose conformity, with notably large differ-
ences of about 20% for the PTV of case 1 and the LDP PTV of case 5 (see also colour maps
in figure 3.5). In some cases, dose to the OARs could be decreased with the 2D-bMLC plans
(e.g. bladder in case 1 and 2, parotid glands in case 3, femoral heads in case 5). However, the
differences in dose to OARs were seen as clinically rather insignificant. In all cases, the mean
dose to the normal tissue is reduced by more than 10% in the 2D-bMLC plans compared to HT
(Maximum difference ∼ 30% in case 1).
3.5 Discussion
2D-bMLC treatment planning
The TPS optimises directly a set of machine parameters, namely the channel opening times and
the machine dose rate for each arc segment. The optimisation constraints ensure, that the final
parameters are physically achievable. The proposed algorithm could therefore be classified as
a direct aperture optimisation (DAO). Overall, the optimisation cannot directly be compared
to DAO proposed for IMRT with a conventional MLC, because the two collimator concepts
differ fundamentally (Hårdemark et al., 2003; Li et al., 2003; Otto, 2008b; Romeijn et al., 2005;
Shepard et al., 2002). However, some principals were adopted, especially the concept to ‘price’
potential apertures and to make the prices the basis of decision for aperture selection. Of course,
the character of an aperture is different in our case: Because of the individual control each 2D-
bMLC channel can be seen as an aperture, and for one arc segment all ‘channel apertures’ can
be selected independently. We use the pricing concept, for the iterative switching between the
channel states open and closed (section 3.3.2.4).
In the TPS the arc segments are approximated by fixed beam directions and the channel dy-
namics are ignored. In contrast, the time-dependent MC simulations include a realistic model
of the collimator absorber and gantry dynamic. The MC tool was primarily developed in order
to study the influence of the dynamics onto the dose distributions. Furthermore, leakage dose
and tongue-and-groove effects are modelled in a more realistic way than in the TPS. In order
to avoid additional discrepancies in the dose distributions, the patient geometry is modelled in
the MC simulations as a set of voxels of water with different electron densities. (Ma and Li,
2011) showed for fixed beam directions that, using water with different electron densities, MC
calculated photon doses are very similar to those calculated with a pencil beam dose algorithm
(PB). To make sure that our PB agrees with the MC calculations, we performed a systematic
testing in water phantoms for different (time-independent) configurations. Therefore, the dif-
ferences seen for the patient plans are real effects due to the added dynamics, leakage and or
tongue-and-groove. (Altenstein et al., 2012b)
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Table 3.2: Dose reports for cases 1 and 2. DVH parameters are defined in 3.3.4. 2D-bMLC
plans are identified by their fractional treatment time TF. Parameters are given for these plans
as calculated with the TPS (in black) and with the MC tool (in grey). Most critical OARs were
included into the tables. Major differences between HT and 2D-bMLC plans are highlighted
with boxes. Units: Doses are given in Gy, VXGy in percent, TF in s, D˙max in MU/min
(a) Case 1: Prostate ca.
HT 20s 10s
TF 129 20 10
D˙max 880 2000 4000
PTV
D98% 74.1 73.2 73.4 73.1 72.8
D50% 80.0 79.5 80.0 79.5 80.0
D2% 83.3 81.8 83.6 82.0 84.3
V95% 94 92 91 91 89
UI 1.09 1.09 1.11 1.09 1.12
CI 1.25 1.07 1.08 1.06 1.08
Rectum
D2% 74.1 73.9 74.1 74.0 74.0
V50Gy 10 13 12 13 13
V70Gy 3 4 4 4 4
Bladder
D2% 81.8 80.3 81.0 80.3 81.1
V50Gy 35 21 21 21 21
V70Gy 17 12 12 12 12
Normal tissue
Dmean 4.5 2.6 3.1 2.6 3.1
(b) Case 2: Prostate ca. (boost concept)
HT 20s 11s
TF 289 20 11
D˙max 880 2000 4000
PTV boost
D98% 70.0 71.5 71.7 71.6 71.3
D50% 76.5 76.3 76.5 76.2 76.5
D2% 80.0 78.7 79.8 79.9 81.4
V95% 0.91 0.95 0.95 0.96 0.94
UI 1.11 1.07 1.09 1.09 1.11
CI 1.08 1.05 1.07 1.06 1.08
PTV LDP
D98% 47.2 46.7 47.0 46.4 46.6
D50% 50.7 50.9 51.2 51.0 51.3
D2% 77.4 77.1 77.5 77.3 77.8
V95% 0.97 0.95 0.95 0.94 0.93
UI 1.54 1.56 1.56 1.57 1.57
CI 1.20 1.13 1.15 1.13 1.16
Rectum
D2% 73.7 72.4 72.9 72.7 72.7
V50Gy 14 18 18 16 17
V70Gy 4 4 4 4 4
Bladder
D2% 77.7 77.8 77.9 78.1 78.4
V50Gy 40 26 26 26 25
V70Gy 14 13 14 13 13
Normal tissue
Dmean 13.1 10.4 11.3 10.3 11.3
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Table 3.3: Dose reports for cases 3-5. See table 3.2 for explanations.
(a) Case 3: Oral cavity ca.
HT 25s
TF 410 25
D˙max 880 2000
PTV boosts∗
D98% 66.2 65.6 65.5
D50% 70.1 70.1 70.4
D2% 73.0 71.9 73.8
V95% 0.96 0.95 0.95
UI 1.08 1.07 1.10
CI 1.10 1.03 1.063
PTV LDP
D98% 53.9 53.8 53.6
D50% 58.8 58.3 59.3
D2% 72.3 71.4 73.0
V95% 0.97 0.97 0.96
UI 1.29 1.28 1.31
CI 1.29 1.19 1.213
Parotid glands∗
D2% 41.2 35.0 34.3
Dmean 17.8 12.9 13.5
Normal tissue
Dmean 10.6 8.6 9.5
∗ Parameters are
given for multiple
volumes together.
(b) Case 4: Nasopharynx ca.
HT 25s
TF 490 25
D˙max 880 2000
PTV boosts∗
D98% 66.9 66.6 66.0
D50% 70.2 70.3 70.4
D2% 72.4 72.1 73.6
V95% 0.98 0.98 0.96
UI 1.06 1.06 1.08
CI 1.12 1.07 1.08
PTV LDP
D98% 55.8 55.5 54.7
D50% 64.1 62.3 62.1
D2% 72.0 71.7 73.0
V95% 0.99 99 98
UI 1.26 1.26 1.30
CI 1.33 1.21 1.21
Optic chiasm
Dmax 45.9 47.6 46.5
Dmean 40.2 34.0 32.9
Optic nerves∗
Dmax 49.1 51.7 51.2
Dmean 25.7 17.6 18.3
Inner ears∗
D2% 53.3 55.5 56.7
Parotid glands∗
D2% 71.9 71.4 73.1
Dmean 33.1 33.6 34.1
Normal tissue
Dmean 13.9 11.3 12.2
(c) Case 5: Anal ca.
HT 25s
TF 551 25
D˙max 880 2000
PTV boosts∗
D98% 56.8 56.5 55.6
D50% 58.8 58.7 58.8
D2% 60.0 59.6 61.3
V95% 1.00 0.99 0.98
UI 1.04 1.04 1.07
CI 1.15 1.09 1.12
PTV LDP
D98% 46.4 46.5 46.7
D50% 50.9 50.6 51.3
D2% 59.4 59.2 60.2
V95% 0.96 0.95 0.96
UI 1.21 1.23 1.24
CI 1.21 1.03 1.04
Bowel
D2% 49.0 50.2 50.0
Dmean 11.2 9.8 10.9
Femoral heads∗
D2% 47.3 35.9 37.3
Dmean 34.0 23.7 24.8
Normal tissue
Dmean 12.9 10.3 11.1
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Plan comparison study
For the plan comparison study, plans were generated for many different fractional treatment
times TF. For presentation in this paper, we selected for every case the plan with the minimum
TF, which fulfilled the clinical goals (in addition TF = 40 s for cases 1 and 2).
The presented TPS plans were approved by a radiation oncologist, and the approval was con-
firmed after MC re-computation. Overall, small differences between TPS and MC plans can be
reported: The mean dose to the normal tissue is increased in the MC plans. This is because the
leakage dose is underestimated with the TPS but modelled more appropriately in the MC sim-
ulations. Furthermore, the target dose inhomogeneity is increased with MC. However, relative
difference in UI are below 3% (table 3.2 and 3.3). The opening shift of the absorber channels
introduces an additional fluency modulation of the channel beams. This effect is not considered
in the TPS calculation and is one reason for these differences. But finally, there is an interplay
of several effects (gantry and absorber dynamics, leakage, tongue-and-groove), whose impacts
on the dose distributions is hard to distinguish.
For case 1 and 2, the increase in fractional treatment time from 20 to 40 s resulted in better
sparing of the rectum and the bladder, but the differences were seen as not clinically significant.
Additional calculations showed that dose to the OARs could not noticeably be reduced by
further increasing TF. In general, a longer TF always leads to a better result by means of
minimisation of the objective function given in equation 3.8, whereas above a certain TF,
differences tend to be minor. (A more detailed study of the influence of TF on the dose distri-
butions is presented in section 4.3).
Shorter TF are possible, if
Dmax is increased. However, a decrease in TF implicates a reduced value domain of permitted
opening times τjk. An increase of
Dmax and a decrease of TF by the same factor should therefore implicate worse results by
means of minimisation of the objective function. However, the plans 10s and 11s (4000MU/min)
calculated for case 1 and 2 respectively, were acceptable with only minor differences to the plans
20s (2000MU/min).
In comparison to the HT reference plans, the 2D-bMLC showed comparable plan quality. The
mean dose to the normal tissue could be reduced with the 2D-bMLC treatment plans. The
differences are comparable to those observed between IMRT treatments and HT (Sterzing et al.,
2008b). Dose to the normal tissue can be reduced in HT treatments if the dynamic jaw mode
is used (Sterzing et al., 2010b). For our comparison study HT was planned with regular fixed
jaw mode.
Hardware limitations
For the current planning study we based all hardware constraints, like gantry speed, channel
opening times or dose rates on potentially realistic assumptions. Gantry speed and dose rates
up to 2000MU/min are currently already achieved in modern linear accelerators like HT or
flattening filter free devices (Mackie et al., 1999; Salter et al., 2011). For the channel opening
time new advanced drive concepts like piezo-electric motors need to be investigated. A detailed
discussion on the possible mechanical realisation of the concept is outside the scope of this
paper.
For this first study, 2D-bMLC plans were calculated for fixed collimator angle and couch po-
sition. The gantry speed was not changed during a treatment. Variations of these parameters
could in principal be added to further improve the dose distributions. The 2D-bMLC treat-
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ments could also be extended to several gantry rotations, e.g. with multiple target points or
helical delivery.
The special design of the 2D-bMLC is notably sensitive to geometrical misalignments of the
absorber modules or of the collimator as a whole. MC calculations for static fields showed, that
already very small rotational misalignments of the collimator can lead to significant decreases
in the energy fluency of the fields (Altenstein et al., 2012c). As one of the next steps, we will
investigate the influence of misalignments onto 2D-bMLC patient plans. Furthermore, we will
also study, how intrafraction motion would affect the planned doses.
3.6 Conclusion
The 2D binary multileaf collimator is a novel collimator concept aiming at very quick aperture
modulations. In order to test, if the 2D-bMLC concept is in principal adequate for radiother-
apy treatments, a planning framework for rotational IMRT treatments with a 2D-bMLC was
developed. A planning comparison was performed for 5 different clinical indications. The 2D-
bMLC plans fulfilled the clinical goals, and dosimetric parameters were comparable to those of
clinically approved Tomotherapy plans. With a FFF linac source and a maximum dose rate
of 2000MU/min, scheduled delivery times of the 2D-bMLC treatments were estimated between
20 and 25 s. With an even increased dose rate, potential delivery times down to 10 s become
possible.
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3.A Details: Finite Parallel Pencil Beam Model for the Treat-
ment Planning Tool KonRadXP
3.A.1 Dose calculation engine of the treatment planning tool KonRadXP
The TPS for 2D-bMLC treatments, described in section 3.3.2, uses the treatment planning tool
KonRadXP for calculation of the dose deposition coefficients Dijk. The coefficient Dijk gives
the dose deposited per unit intensity of bixel jk (channel j in arc segment k) to a voxel i of the
patient geometry. Hence, before the TPS starts the plan optimisation, for every bixel jk the
dose at any voxel i is calculated and stored in the matrix (Dijk).
KonRadXP was developed at the German Cancer Research Center and was originally presented
by Nill (2001). A finite pencil beam (PB) dose calculation model is used for computation of the
dose deposition matrix. The model relies on pre-calculated dose distributions: For a given source
and a given bixel resolution, a 3D water-dose distribution of a finite parallel PB, i.e. a non-
divergent PB, must be available. Any dose calculation method can be used to assess these PBs.
The advantage of using a non-divergent PB, is that only one PB has to be calculated for any
source-surface distance. If the finite PB input data is available, the dose engine of KonRadXP
allows to calculate 3d dose distributions in any patient geometry. A detailed descriptions of
the PB model and the dose engine can be found in (Nill, 2001, chap. 3) and in (Bortfeld et al.,
1993).
3.A.2 Calculation of a finite parallel pencil beam for 2D-bMLC treatments
For the integration of the 2D-bMLC treatments into the dose engine of KonRadXP, a finite
parallel photon PB was calculated in two steps. At first, the 3D water-dose distribution of a
single divergent 2D-bMLC channel beam was assessed using MC simulations and the collimator
model presented in chapter 2. Then, the dose distribution was converted into a non-divergent
coordinate (fan-line) system, as required as input data.
3.A.2.1 MC simulation of a divergent 2D-bMLC beam
The setup of the MC simulation is shown schematically in figure 3.7. The setup is similar to
that used for the dosimetric evaluation of the 2D-bMLC (see figure 2.5(a)). Also, the virtual
photon source model and the 2D-bMLC model were the same as presented in chapter 2.
The pre-collimator was adapted, so that its projected field size at the isocentric plane would
be 20×20 mm2. All absorber channels were closed except one of the most central channels,
channel 1515 following the indexing defined in section 2.3.2. The collimator was tilted around
the photon source, so that the beam of the open channel targeted the isocenter of the treatment
machine, but that the channel remained full focusing at the same time (see also figure 2.22).
The water phantom was modelled as a box of liquid water with the dimensions 500×500×400
mm3 (400 mm in z-direction). The SAD was 800 mm, and the source surface distance (SSD)
was 700 mm. The dose was scored within the phantom with a lateral resolution of 0.5 mm and
a z-resolution of 2 mm. Finally, the dose distribution was scaled to 1 monitor unit (MU) and
stored. 100 MU correspond to 1 Gray calculated in the isocenter for an open 100×100 mm2
field, a SAD of 1000 mm and a SSD of 950 mm (same photon source and water phantom).
The simulation was split up in two parts. In a first part the transport of the source photons
through the the collimator was simulated, and the phase space was scored downstream the
collimator, in the phase space plane shown in green in figure 3.7. In a second part the parti-
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Figure 3.7: Scheme of the simulation setup for the central bixel (simplified two-dimensional
illustration)
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cle transport through the water phantom was simulated and the dose deposition was scored.
Thereby, a common variance reduction method was applied: Each phase space particle was
reused 20 times, but each time with an independent serial of random numbers. The simulations
were performed in multiple parallel jobs.
The simulations were implemented with Geant4 version9.4p02. A Geant4 standard electromag-
netic physics list with best advanced electromagnetic options was used3. The electron step size
was limited to 0.05 mm.
3.A.2.2 Conversion into a finite parallel PB
  
source
surface
d
x
y
  
source
surface
d
pb
x
pb
y
pb
Divergent beam Parallel finite pencil beam
central axis central axis
SSD
isocenter
SAD SSD SAD
isocenter
Figure 3.8: Divergent beam coordinate system and non-divergent coordinate system, in which
the finite parallel pencil beam is stored.
The coordinate system, in which the MC calculated dose distribution of the divergent channel
beam has been calculated and stored, is shown in figure 3.8 on the left side. Pu is the dose
to a voxel u with the coordinates xu, yu and du. We define a second coordinate system for
the finite parallel pencil beam (referred to as PB system) shown on the right side of figure 3.8.
In principal, both coordinate systems are similar: The lateral coordinate axes are identical to
3The physics list was similar to that which is loaded with the physics list constructor emstandard_opt3. The
physics list constructors are developed and maintained by the electromagnetic working group of the Geant4
collaboration. Further information can be found on http://geant4.web.cern.ch/geant4/collaboration/
working_groups/electromagnetic/physlist.shtml.
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those of the IEC gantry system, and the depth d is defined in the negative z-direction of the
IEC gantry system (figure 2.5(b)). The origin is located at the patient’s or phantom’s surface.
The dose distribution of the finite parallel pencil beam was calculated for a regular grid with
the same resolution as the grid used in the MC simulations (voxel size 0.5×0.5×2 mm3). xpbv ,
ypbv and dpbv are the coordinates of voxel v in the PB dose cube; P pbv is the PB dose to voxel v.
The conversion of the MC calculated dose distribution into the PB dose distribution was per-
formed voxel-wise. The following routine was applied for every voxel v of the PB dose cube in
order to assess the entry P pbv :
1. The coordinates xpbv , ypbv and dpbv of the voxel v are converted into the divergent beam
system using
xv = x
pb
v · SSD + d
pb
v
SAD
(3.19)
yv = y
pb
v · SSD + d
pb
v
SAD
(3.20)
dv ' −SSD +
√(
dpbv + ξ
)2 − xv2 − yv2 (3.21)
with
ξ =
SSD
SAD
√(
xpbv
)2
+
(
ypbv
)2
+ SAD2 . (3.22)
SSD is the source-surface distance, SAD the source-axis distance (see also figure 3.8). The
approximation in equation 3.21 is justified by xpbv and ypbv  SSD.
2. P (dv, xv, yv), the dose at point (dv, xv, yv) in the divergent beam system, is assessed from
the MC calculated 3D water-dose distribution by tri-linear interpolation.
3. The dose entry P pbv to voxel v in the PB system is determined by
P pbv = P (dv, xv, yv)
[
SSD + dv
SAD
]2
. (3.23)
In figure 3.9, we show dose maps and profiles for the final finite parallel pencil beam, which was
used for dose calculation in KonRadXP.
3.A.3 Bixel spot positions for 2D-bMLC treatments
For KonRadXP, a bixel is specified by a set of parameters. Beside gantry angle, collimator angle
and patient table angle, also the bixel spot position has to be given. The bixel spot position
is defined by the x- and y-coordinates, that the bixel beam spot would have in the isocentric
plane for gantry and colli angle 0 (see figure 3.10(a)).
In a 2D-bMLC treatment the bixels correspond to the 2D-bMLC channel beams. Therefor,
the center of the theoretical projections of the channel openings onto the isocentric plane, were
defined as the possible bixel beam spot positions. The center of a beam spot was calculated
as the midpoint of the vertexes given in equation 2.27. In figure 3.10(b), we show all possible
bixel spot positions for the 2D-bMLC in a scatter plot.
An adaptation of the dose calculation to other collimator or treatment design variations, as e.g
the variations discussed in section 2.B.3, could be realised by adjusting the bixel beam spot
positions respectively.
72
3.A. Details: Finite Parallel Pencil Beam Model
xpb [mm]
dp
b  
[m
m]
−10 0 10
0
50
100
150
200
250
300
350
ypb [mm]
 
 
−10 0 10
0
50
100
150
200
250
300
350
0
0.5
1
[rel. unit]
(a) 2D views of the dose distribution through the
isocenter
−20 −10 0 10 20
0
0.2
0.4
0.6
0.8
1
xpb [mm]
do
se
 [re
l. u
nit
s]
−20 −10 0 10 20
0
0.2
0.4
0.6
0.8
1
ypb [mm]
do
se
 [re
l. u
nit
s]
(b) Lateral profiles for a depth of 50 mm
0 50 100 150 200 250 300 350
0
0.2
0.4
0.6
0.8
1
dpb [mm]
do
se
 [re
l. u
nit
s]
(c) Depth dose curve on central axis
Figure 3.9: Finite parallel PB for the dose calculation engine of KonRadXP.
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Figure 3.10: (a) The bixel spot position is defined by the x- and y-coordinates, that the bixel
beam spot would have in the isocentric plane for gantry and colli angle 0. (b) Possible bixel
beam spot positions for the 2D-bMLC.
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Chapter 4
Sensitivity of treatment plan quality to
TPS parameters
4.1 Overview
In this chapter, we present three additional planning comparison studies performed with the
treatment planning system (TPS) presented in chapter 3. In the first study (section 4.2), the
influence of Nseg on the final dose distribution was investigated for six patient cases. Based on
the results of the study, we recommend a minimum number Nseg of 72. However, for patients
with very large and complex target volumes, an increase of Nseg might be appropriate.
The goal of the second study (section 4.3) was to better understand the potential influence of
TF on the dose distributions optimized with the TPS. For the same six patient cases, 2D-bMLC
plans were computed for different TF, holding the other planning parameters fixed. Below a
critical TF, e.g. 16 s for a prostate case for which a very detailed analysis was performed, target
coverage was insufficient. Above this value doses to the target volumes were rather independent
on TF, but the doses to several organs at risk did show a strong dependence on TF.
In the third study (section 4.4), prostate plans were calculated for a regular fractionation
regimen and for extreme hypofractionation. The plans should be equivalent concerning target
coverage and sparing of OARs. It could be shown, that therefore the fractional delivery time
TF could be scaled with the fraction size.
Publication
Results from section 4.4 have been presented at the international ESTRO 33 Conference in
Vienna, Austria, April 2014 (Altenstein et al., 2014).
4.2 Study of the Influence of Nseg
4.2.1 Introduction
The number of arc segments Nseg is one of the treatment parameters that have to be defined
before plan optimisation (see section 3.3.2.1). In this study, the influence of Nseg on the final
dose distribution was investigated for 6 cases. The goal was to find the minimum necessary
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number Nseg for each case respectively, and to give a guideline for the choice of Nseg for future
patient plans.
4.2.2 Methods
The study was performed for cases 1 to 5 described in section 3.3.4 and for an additional
prostate case (case 6). Dose prescriptions for cases 1 to 5 are summarised in table 3.1. The
dose prescriptions for case 6 were as follows: 76 Gy median dose in 35 fractions were prescribed
to the prostate (PTV 1), 70 Gy median dose to the a volume including the prostate and seminal
vesicles plus a 7 mm margin (PTV 2). For each case 2D-bMLC plans were optimised with Nseg
of 48, 72 and 96. For cases 1 and 6, with relatively small target volumes, additional plans were
computed with Nseg equal to 36. Other planning parameters, including the penalty values for
overdosage and underdosage, were hold unchanged for each case respectively. D˙min and D˙max
were 500 and 2000 MU per minute respectively. TF was 20 s for case 6, and the values for cases
1-5 are specified in table 3.1. The target point, coincident with the point of rotation of the
treatment, was at the center of mass of the primary PTV ± 5 mm.
For this study, the TPS calculated dose distributions were used for plan evaluation. The plans
were evaluated by visual inspection and dvh analysis. Finally, for each patient the minimum
number Nseg, necessary to assure sufficient target dose coverage and uniformity without hotspots
in the normal tissue, was identified. For verification the selected plans were recalculated with
the 4D MC tool, which considers gantry and collimator dynamics appropriately (see section
3.3.3).
4.2.3 Results and discussion
As an example, we show dose distributions calculated for case 6 in figure 4.1. The dose dis-
tributions shown in figure 4.1(a) and 4.1(b), for Nseg 36 and 48 resp., show significant dose
inhomogeneities close to the PTV 2. Therefor, the plans were rejected. Nseg=72 however was
sufficient to assure good target dose coverage and uniformity, and no significant improvement
could be obtained with Nseg=96.
In general, the following characteristics were observed, if Nseg was not sufficient: Dose inho-
mogeneities close to or within the target volumes, insufficient target dose coverage, dose hot
spots in the normal tissue and OARs. These characteristics lead to rejection of the plan and
the respective number of arc segments.
The minimum necessary number for Nseg for the six cases were:
Case Volume of largest PTV Nseg
1. Prostate only 74ml 48
2. Prostate boost 1040ml 72
3. Oral cavity 1083ml 72
4. Nasopharynx 1324ml 72
5. Anal 3329ml 96
6. Prostate 2 170ml 72
A number of 48 arc segments was only sufficient for the prostate only case with a relatively
small target volume. For all other cases Nseg = 72 was acceptable, except for the anal carcinoma
case with very large and complex PTVs (see also table 3.1 and figure 3.5).
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Figure 4.1: Dose maps of 2D-bMLC plans calculated for case 6 for different Nseg. Other
treatment parameters were the same for all plans. The thin black line corresponds to the 95%
isodose of PTV 2.
4.2.4 Conclusion
For the planning of 2D-bMLC treatments, we propose a minimum number of 72 for Nseg. This
number should ensure sufficient target coverage for a wide range of target volumes. For patients
with very large and complex targets, such as for the patient with anal cancer (case 5 → see
also sections 3.3–3.4), Nseg might be increased to 96 or to an even larger number as necessary.
PTV volumes may be used as indicators for the choice of Nseg, however, extent and complexity
of the target volume should also be considered.
Another option would be to use a larger number of Nseg, such as 96 or larger, for all cases. But
of course, a larger Nseg implies smaller arc segments and can possibly result in more opening
and closing shifts per treatment. And finally, because of equation 3.4, an unintended lower
bound for TF can also be the consequence of larger Nseg.
4.3 Study of the Influence of TF and Comparison to a ‘Best Case’
IMRT plan
4.3.1 Introduction
Beside Nseg, also the fractional treatment time TF is a planning parameter, that currently has
to be set before plan optimisation (see section 3.3.2.1). In this study, 2D-bMLC treatment
plans were calculated for different TF, whereas Nseg was not changed. The goal was to better
understand the potential influence of TF on the optimisation result and hence on the final dose
distributions. A very detailed study was performed for a prostate case. In addition, the 2D-
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bMLC plans for this case were compared to a potential ‘best case’ IMRT plan, optimised for a
conventional MLC and for 180 beam directions.
4.3.2 Methods
The study was performed for cases 1 to 5 described in section 3.3.4 and for an additional
prostate case (case 6). For case 1 to 5, with the dose prescriptions given in table 3.1, plans were
optimised for two different TF respesctively: For 20 and 40 s for the prostate cases 1 and 2, and
for 25 and 40 s for cases 3 to 5.1 Other planning parameters than TF, including the penalty
values for overdosage and underdosage, were hold unchanged for each case respectively. D˙min
and D˙max were set to 500 and 2000 MU per minute respectively.
A more detailed study was performed for case 6. Dose prescription were as follows: 76 Gy
median dose in 35 fractions were prescribed to the prostate (PTV 1), 70 Gy median dose to a
volume including the prostate and the seminal vesicles plus a 7 mm margin (PTV 2). 2D-bMLC
plans were calculated for TF of 14, 16, 18, 20, 25, 30, 40 and 60 s. In the following, the plans
are labelled by their TF. Again, other planning parameters were hold fixed. Nseg was 72, D˙min
and D˙max were 500 and 2000 MU per minute respectively. For comparison, an additional plan
(referred to as 2D-bMLC*) was optimised without constraints on TF, thus without maximum
channel opening time per arc segment.
The TPS calculated dose distributions were used for a first plan evaluation. The plans were
evaluated by visual inspection and by visual and quantitative dvh analysis. The plans for the
cases 1 to 5 were partly recalculated with the 4D MC tool (see section 3.3.4). For these cases,
the MC doses were used for a final plan evaluation. The 4D MC tool considers gantry and
collimator dynamics appropriately (section 3.3.3).
For case 6, the clinically applied IMRT plan with eight beam directions was used as reference
(referred to as IMRT ref.). The plan was made for the Siemens ARTISTE 6 MV 160 MLCTM .
Additionally, a hypothetical IMRT plan for the FFF Siemens ARTISTE 7 MV 160 MLCTM
and for 180 beam directions was calculated (IMRT 180). The algorithm used for the inverse
optimisation of the latter plan was chosen in such a way, that major discrepancies in the dose
distributions to those of the 2D-bMLC plans should only be caused by the differences in the
treatment modalities, and especially the constraints used for the 2D-bMLC plans. Discrepancies
due to the optimisation algorithm should be relatively small. No constraints were used for the
fluency maps of plan IMRT 180, and no post-processing (sequencing) was applied after plan
optimisation.
4.3.3 Results and discussion
Here, we particularly focus on case 6. Plan 14s was rejected because of insufficient target dose
coverage. The treatment time was simply not long enough to deliver enough dose to the PTVs.
However with TF ≥ 16 s, the clinical goals concerning target coverage were fulfilled. Moreover,
with TF ≥ 18 s, all 2D-bMLC plans had very similar DVHs for PTV 1 and 2.
Exemplary for the 2D-bMLC plans with TF ≥ 18 s, we compare in figure 4.2(a) and 4.2(b) the
PTV DVHs of 20s to those calculated for IMRT ref. and IMRT 180. IMRT 180 represents, so to
say, a ‘best case’ reference, which could be achieved with the Siemens 160 MLCTM . Concerning
doses to PTV 1, differences between the 2D-bMLC plans (TF ≥ 18 s) and the reference plans
were small, also in quantitative DVH analysis. However, larger differences can be reported for
1The plans have already partly be presented in sections 3.3 and 2.4.
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Figure 4.2: DVHs for case 6. The 2D-bMLC plans are labelled with the respective TF. IMRT
180 is the IMRT plan calculated for a conventional MLC and 180 beam directions. IMRT ref.
is the clinically applied reference plan. All 2D-bMLC plans with TF ≥ 18 s had very similar
DVHs for PTV 1 and 2.
the dose conformity. The conformity index2 was 1.20–1.22 for the 2D-bMLC plans, compared
to 1.59 for IMRT ref. and 1.16 for IMRT 180.
The minimum dose D98% to PTV 2 was 95–97% of the prescription dose for 2D-bMLC, 94%
for IMRT ref. and 99% for IMRT 180. Also concerning 95%-coverage, the 2D-bMLC plans
(V95% = 99%) performed better than IMRT ref. (97%) but slightly worse than IMRT 180
(100%). Dose uniformity and conformity for PTV 2 were similar for all plans.
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Figure 4.3: Dose maps of 2D-bMLC plans with different TF and of plan IMRT 180 calculated
for case 6. The thin black line corresponds to the 95% isodose of the PTV 2.
The doses to the OARs were partly strongly dependent on TF, also for TF ≥ 18 s. Here,
we want to refer to figure 4.3(a) and 4.3(b), were dose maps are shown for the plans 20s
and 60s respectively. The differences in the two dose maps can be explained as follows: The
maximum opening time per arc segment is directly proportional to TF. Thus, if TF is longer,
the constraints on the optimisation parameters, namely the opening times per channel and arc
segment, are relaxed; the potential to attach more weight to individual bixels, in order to better
conform the dose to the target, is increased. One can clearly see in the figures, that especially
the rectum dose is reduced if TF is increased from 20 to 60 s. In figure 4.3(c), the dose map for
the ‘best case’ reference plan IMRT 180 for the same slice is shown.
2See section 3.3
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The penalty values for the optimisation were chosen in that way, that target coverage was
prioritised. Therefor, a reduced potential for beam modulation pre-dominantly affects the doses
to the OARs, especially to the rectum which is partly enclosed by the PTV 2. Consequently,
the DVH of the rectum largely depend on TF, as can be seen in figure 4.2(c). The DVH of 60
is very similar to that of IMRT 180. With increasing TF, the DVH lines are quasi shifted to
higher doses.
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Figure 4.4: DVH analysis for case 6. The parameters assessed for the 2D-bMLC plans are
plotted against TF. 2D-bMLC* is a ‘step-and-shoot’ 2D-bMLC plans without constraints for
the delivery time per arc segment. IMRT 180 is the IMRT plan calculated for a conventional
MLC and 180 beam directions. IMRT ref. is the clinically applied reference plan.
In figure 4.4, DVH parameters assessed for the rectum, the bladder, the right femoral head and
the normal tissue VOI (body without PTV 2) are plotted against TF. For these OARs the
DVHs were clearly dependent on TF, including the other femoral head. The dependence is also
reflected in the final value of the objective function, which is minimised in the optimisation
process (figure 4.4(f)).
For all shown DVH parameters, a smaller value is preferable. The parameters decrease with TF
approaching the level of the unconstrained 2D-bMLC plan denoted 2D-bMLC* (blue line). For
all OARs, this level, which clearly fulfils the clinical goals, is approximately reached with TF 60
s. The parameters calculated for the ‘best case’ reference (dashed green line) are comparable
to those of 2D-bMLC*. IMRT 180 performs slightly better concerning doses to the bladder
and the normal tissue VOI, but slightly worse concerning V50% and V80% for the rectum. As
discussed before, IMRT 180 should in principle represent the best possible plan. However, due
to the differences in the optimization strategies and the employed stopping criteria, it is also
possible, that a 2D-bMLC plan somewhat better fulfils certain optimization goals. Overall, the
differences between 2D-bMLC* and IMRT 180, thus between the dashed green and the blue lines
in figure 4.4, were estimated as clinically not relevant. The parameters assessed for the clinical
reference plan IMRT ref. are added to the plots as dash dotted red lines. Only for TF below 20
s, the 2D-bMLC plans exceed this level.
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Figure 4.5: DVH comparison of 2D-bMLC plans calculated with different TF (thin lines).
HT is the helical Tomotherapy reference plan, which had be applied clinically.
The femoral heads were the only OARs for which the maximum doses D2% had a considerable
dependence on TF. For both femoral heads the dependence was very similar, and for all 2D-
bMLC plans D2% to the femoral heads was smaller than for IMRT ref..
For the other cases, similar results can be reported. In section 3.4 the plans 20s respectively
25s were already discussed in detail and compared to the HT reference plan. Overall, target
coverage did not change considerably if TF was increased to 40 s. However, doses to several
OARs did show a dependence on TF, especially the parotid glands for the head-and-neck cases
3 and 4 and the femoral heads in the anal carcinoma case 5 (see figure 4.5). But finally, the
differences were seen as clinically rather insignificant.
For the prostate cases 1 and 2, the differences between 20s and 40s were already reported in
section 3.4.2. Consistently with the results for case 6, the increase in fractional treatment time
from 20 to 40 s resulted in better sparing of the rectum and the bladder (see also figure 3.6(b)).
However, also for case 1 and 2, the differences were seen as not clinically significant.
4.3.4 Conclusion
Below a critical TF, e.g. 16 s for case 6, target coverage was insufficient. Above this value
PTV doses were rather independent on TF, but the doses to several OARs did show a strong
dependence on TF. Concerning PTV coverage and doses to the OARs, the plans calculated for
TF of 20 or 25 s were comparable to the clinical reference plans. The potential to spare the
OARs was further increased with TF until saturation was reach at about 40–60 s.
It needs to be noted that a shorter delivery time can lead to inferior optimisation results. Finally,
a careful weighing up of shorter delivery time and better plan quality might be necessary for
each clinical indication or even each patient geometry.3
3As a side node, we want to add, that for cases with breathing induced motions, one could also think about
a modified treatment mode with delivery in several fast rotations in a repeated manner. Such a technique could
be combined with a breath holding technique to reduce motion during each rotation.
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4.4 Hypofractionated Prostate Plans
4.4.1 Introduction
Hypofractionated treatments are delivered in fewer fractions with larger fraction doses. It has
been hypothesised, that hypofractionated treatments are favourable for some tumours with low
α/β ratio. Several clinical studies have been performed or are still ongoing to clarify the role
of hypofractionation for prostate cancer treatments.(Brenner and Hall, 1999; Cabrera and Lee,
2013; Lee, 2013; Oliveira et al., 2012; RTOG, 2013)
For this study, 2D-bMLC prostate plans were calculated for three different fractionation regim-
ina. The plans should be equivalent concerning target coverage and sparing of OARs. We
wanted to show, that therefor the fractional delivery time TF can be scaled with the fraction
size. Furthermore, the same plans were also used in the study about the impact of intrafraction
motion presented in section 5.3.
4.4.2 Methods
The clinical target volume (CTV) was the same as the Gross Tumour Volume (GTV) and
consisted of the prostate only. The PTV was defined as the CTV plus a 3 mm margin posteriorly
and a 5 mm margin in all other dimensions. Plans were calculated for the following fractionation
schemes:
Plan Prescription dose
F35 D95% ≥ 35× 2.1Gy (Total dose 73.5Gy)
F12 D95% ≥ 12× 4.3Gy (Total dose 51.6Gy)
F5 D95% ≥ 5× 7.25Gy (Total dose 36.25Gy)
The isodose line used for the prescription dose should cover a minimum of 95% of the PTV.
Target delineation as well as the prescriptions for the two hypofractionated treatments F5 and
F12 followed the RTOG 0938 protocol (RTOG, 2013). A corresponding standard fractionation
scheme was used for F35.
All plans were optimised for 72 arc segments. D˙min and D˙max were 500 and 2000 MU per
minute respectively. TF was 65 s for F5, 40 s for F12 and 20 s for F35. TF was approximately
scaled with the fraction size. For MC recalculation the dimensions of the pre-collimator field
were set to 120×80 mm2 (in the isocentric plane). The resolution of the voxel grid was 1×1×2
mm2 (same as CT data set). F d>0.5dmax of the final MC dose distributions was about 1%. The
MC calculated plans were rescaled to match the dose prescriptions for the PTV. The Plans
were evaluated by visual inspection of the dose distributions and by visual and quantitative
dvh analysis.
4.4.3 Results and discussion
Comparing the results of the calculation methods separately (TPS or MC), F5, F12 and F5 have
very similar dose distributions - of course relatively seen to the respective prescription dose.
Small differences can only be reported for the MC calculated plans, and that only for D2%, UI
and CI for the PTV (see table 4.1). Differences in the doses to the OARs are insignificant.
These differences can be explained as follows: As already discussed in section 3.5, the MC plans
generally show increased target dose inhomogeneity compared to the TPS plans. The opening
and closing shift of the absorber channels, neglected in the TPS calculations but modelled in the
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Table 4.1: PTV report for prostate plans with different fractionation regimina. TPS results
are given in black, MC results in grey. All dose values are given as percentage of the respective
prescription dose. DVH parameters are defined in section 3.3.4.
F35 F12 F5
Prescr. [Gy] 73.5 (35×2.1) 51.6 (12×4.3) 36.25 (5×7.25)
TF [s] 20 40 65
PTV
D98% [%] 98.7 98.8 98.8 98.8 98.8 98.8
D50% [%] 102.1 104.1 102.0 103.6 102.0 103.4
D02% [%] 104.6 108.6 104.5 107.5 104.6 107.0
V100% [%] 95 95 95 95 95 95
CI 1.16 1.27 1.15 1.25 1.15 1.24
UI 1.04 1.08 1.04 1.07 1.04 1.06
MC simulations, is the main reason. The more shifts are modelled, the more the effect should
carry weight. And as a matter of fact, this effect is less pronounced for the hypofractionated
treatments with larger fraction sizes and overall less required opening/closing shifts. This trend
can be seen in figure 4.6, where PTV DVHs are shown for F5 and F35. In table 4.1, the increase
in target dose inhomogeneity is reflected in larger values of the uniformity index UI and the
maximum dose D2%. Due to the rescaling also the conformity index CI is slightly increased,
but the dose coverage (V100%) and the minimum dose D98% are not affected.
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Figure 4.6: Prostate plans with standard fractionation and extreme hypofractionation: DVHs
of the PTV for the TPS plan and the MC recalculated and rescaled plan. The dose is given
as percentage of the prescription dose, 73.5 and 36.25 Gy respectively.
Overall, the results confirm the hypothesis, that for calculating 2D-bMLC plans for different
fractionation schemes, the fractional delivery time TF can be scaled with the fraction size. As
discussed in the previous paragraph, the small discrepancies in the relative dose distributions
are rather due to the different fraction numbers and not influenced by TF.
For the three fractionation schemes, TF was below delivery times typical for the treatment
techniques applied in the clinics today. With volumetric modulated arc therapy (VMAT) (Otto,
2008a; Ulrich et al., 2007a; Wang et al., 2008; Yu, 1995), delivery times of about 1 minute are
possible for standard fractionation (fraction size 2 Gy) (Thomas et al., 2013). In comparison,
the scheduled TF of the 2D-bMLC treatment was 25 s. In general, delivery times of VMAT are
below or in the same range of those of other clinical techniques (Bedford, 2009; Palma et al.,
2008; Wolff et al., 2009).
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For extreme hypofractionation with only 5 fractions and a fraction dose of 7.25 Gy, TF of
the 2D-bMLC plan was 65 s. For a similar fractionation regimen (35 Gy minimum dose in 5
fractions), MacDougall et al. (2014) reported delivery times of about 3 minutes for VMAT with
a flattened linac beam. With a flattening filter free 10 MV linac and a maximum dose rate of
2400 MU/min, delivery times of about 2 minutes can be achieved, as reported by Alongi et al.
(2013).
4.4.4 Conclusion
For calculating 2D-bMLC plans for different fractionation schemes, the fractional delivery time
TF can be scaled with the fraction size. Target dose inhomogeneity of the MC calculated
plans is affected by the number of modelled opening and closing shifts. Therefore, target dose
inhomogeneity was slightly reduced in the hypofractionated treatment regimina with fewer
fraction numbers and overall less required opening/closing shifts. The delivery times of the 2D-
bMLC treatments were below typical delivery times of clinically applied treatment techniques.
84
Chapter 5
Impact of Geometrical Misalignment
and of Intrafraction Motion on
2D-bMLC doses
5.1 Overview
The design of the 2D-bMLC differs substantially from the design of conventional MLCs. Firstly,
the radiation fields are spatially fractionated into stripes. The fractionation is inherent to the
system. Secondly, the fields are formed by long and thin absorber channels. Because of these
two special characteristics, the 2D-bMLC treatments might be notably sensitive to geometrical
misalignments of the collimator on the one hand, and to patient motion during treatment
delivery, also referred to as intrafraction motion, on the other hand. Both aspects have been
investigated in MC studies that we present in this chapter.
In the first study, we analysed in detail the influence of collimator misalignments on the primary
radiation efficiency (section 5.2). The possible impact of variations of the linac source size
were also examined. The goal of the second study was to estimate the dosimetric effects of
intrafraction motion for 2D-bMLC treatments (section 5.3). The 4d MC tool was extended,
so that rigid patient motion could be modelled continuously during radiotherapy delivery. The
new feature was used for the motion-encoded recalculation of standard and of hypofractionated
prostate plans.
Publication
Results from section 5.2 have been presented at the 43th Annual Meeting of the German Society
of Medical Physics in Jena, Germany, September 2012 (Altenstein et al., 2012c). Results from
section 5.3 have been presented at the international ESTRO 33 Conference in Vienna, Austria,
April 2014 (Altenstein et al., 2014).
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5.2 Study of the Influence of Geometrical Misalignment on the
Primary Radiation Efficiency
5.2.1 Introduction
With its especially thin absorber channels, the design of the 2D-bMLC (see figure 2.3.1) might
be notably sensitive to geometrical misalignments of the collimator as well as to variations of
the linac source size. Misalignments or variations of the source size can be caused by tolerances
in system installation and calibration.
In chapter 2, we presented the dosimetric properties of the perfectly aligned 2D-bMLC assessed
in MC simulations. The aim of this study was to investigated in detail, how 2D-bMLC fields
are influenced by possible geometrical misalignments and by variations of the source size. A
quantitative analysis was performed for the primary radiation efficiency.
5.2.2 Methods
5.2.2.1 MC setup
The MC setup is shown in figure 5.1. The setup is similar to that used for the dosimetric
characterisation of the 2D-bMLC presented in chapter 2. The 2D-bMLC model with 30 by 30
absorber channels, the pre-collimator and the source model are described in sections 2.3 and
2.A.
2D-bMLC
Photon source 800 mm
 430 mm
    0 mm
 610 mm
Isocentric plane 
(scoring of energy fluence)
Pre-collimator
z
x
y
Figure 5.1: MC setup used to calculate the energy fluency of 2D-bMLC fields in the isocentric
plane.
.
In all MC simulations performed for this study, the central 10 by 10 elements of the collimator
were open. The corresponding pattern of open channels is shown in figure 2.7(a). Different
to the simulations presented in chapter 2, the 2D-bMLC was tilted around the linac source as
described in section 2.B.3.2 by an angle of -αb2 .
1
Downstream the 2D-bMLC in the isocentric plane, the 2D distribution of the absolute energy
1The -αb
2
-tilt was applied in this study in order to reduce the interference of the pre-collimator (see dicussion
in section 2.4.3.1). Additional testing has shown, that relative differences in the primary radiation efficiency
factors calculated with and without the tilt are below 1%.
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fluency was scored in a regular mesh. The scoring resolution was 0.5 mm in both directions.
For a quantitative analysis, primary radiation efficiency factors (EF) of the 2D-bMLC were
calculated by dividing the integral energy fluency in the isocentric plane by the integral energy
fluency calculated for a reference field, an open non 2D-bMLC 100mm-square field, in the same
plane. Additional calculations have shown, that values of EF estimated that way were very
similar to values calculated with the method described in 2.3.3.3, but that calculation times
were reduced significantly.
The MC simulations were performed with Geant4 release 9.5. A Geant4 standard electromag-
netic physics list with best advanced electromagnetic options was used2.
5.2.2.2 Variations of the MC setup
Six series of MC simulations have been computed. The series are referred to by the lower
case characters a to f. In series a to e, different misalignments of the 2D-bMLC were studied
separately. In series f, 2D-bMLC fields were calculated for different source sizes. The pictograms
in figure 5.2 visualize the geometrical changes of the simulation setup performed in each series
respectively.
(a) Tilt X (b) Tilt Y (c) Shift X
(d) Shift Y (e) Shift Z (f) Source size
z
x
y
MC setup
Figure 5.2: Pictograms of the geometrical variations of the MC setup. The variations were
studied separately in series of simulations. See figure 5.1 for a detailed description of the basic
setup.
In the following, we itemize short explanations of the studied geometrical variations. A simula-
tion parameter is related to each variation respectively, and in the MC series, only one of these
parameters was changed respectively. Following to the descriptions, we give lists of values for
the parameters under examination. For each value a separate MC simulation was performed:
(a) Tilt X → Tilt of the collimator perpendicular to the field stripes
Values tilt angle: 0.0 0.1 0.2 0.3 0.4 0.5 0.7 0.9 deg
2The physics list was similar to that which is loaded with the physics list constructor emstandard_opt3. The
physics list constructors are developed and maintained by the electromagnetic working group of the Geant4
collaboration. Further information can be found on http://geant4.web.cern.ch/geant4/collaboration/
working_groups/electromagnetic/physlist.shtml.
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(b) Tilt Y → Tilt of the collimator in parallel to the field stripes
Values tilt angle: 0.0 0.4 0.8 deg
(c) Shift X → Lateral shift of the collimator perpendicular to the field stripes
Values shift: 0.0 0.4 0.8 1.2 mm
(d) Shift Y → Lateral shift of the collimator in parallel to the field stripes
Values shift: 0.0 0.4 0.8 1.2 mm
(e) Shift Z → Vertical shift of the collimator
Values shift: -1.2 -0.6 0.0 0.6 1.2 mm
(f) Source size → Variation of the std of the Gaussian shaped photon source
Values std: 0.15 0.30 0.45 0.60 0.75 0.90 1.20 1.50 mm
The parameters which were not varied in a series respectively, were set to their basic values: 0
deg for tilt angles, 0 mm for displacement shifts and 0.45 mm for the source std. The basic values
correspond to the perfectly aligned 2D-bMLC and to the source size assessed from experimental
data (see section 2.A).
The tilts performed in the series a and b are small rotations performed around axes through
the geometrical center of the 2D-bMLC (and should not be confused with the tilts around the
source). The axes of rotation were parallel to the y and the x axis of the GANTRY system
(figure 2.5(b)) respectively. The displacement shifts in c, d and e were in parallel to the axes
of the GANTRY system respectively.
Small tilts (up to several degrees) of the collimator around the z-axis should implicate a corre-
sponding rotation of the radiation field, but should not lead to an essential reduction of primary
radiation efficiency. Tilts around the z-axis were therefore not included into the study.
5.2.3 Results
In Figure 5.3, EF is plotted against the different geometrical parameters which have been
under examination. Additionally, we show colour maps and central lateral profiles of the energy
fluency for selected series in figure 5.4 to 5.7. For the profiles in x-direction (perpendicular to
the 2D-bMLC field stripes), the energy fluency was averaged in y-direction from -25 mm to
+25 mm. All values of energy fluency are given relative to the energy fluency calculated in the
center of the reference field.
The following observations can be summarized:
(a) Tilt X: EF falls from approximately 0.44 for tilt angle 0.0 to 0.02 for tilt angle 0.7 degrees
or greater. This corresponds to a relative reduction of 95%. Figure 5.4 shows energy
fluency maps, and lateral profiles of the energy fluency are shown in figure 5.5. For tilt
angles greater than 0.5 degree, cross leakage peaks appear outside the originally collimated
field.
(b) Tilt Y: EF decreases relatively slightly with increasing tilt angle in parallel to the field
stripes. Variations in EF are below 2% for the range under examination.
(c) Shift X: Displacement shifts of 0.4, 0.8 and 1.2 mm lead to relative decreases in EF of
5%, 18% and 33% respectively. The shifts perpendicular to the field stripes also result in
a shifts of the radiation field as can be seen in figure 5.6.
(d) Shift Y: EF decreases relatively slightly with the shift in parallel to the field stripes.
Variations in EF are below 1% for the range under examination.
(e) Shift Z: EF is increased if the collimator is moved towards the source and decreased if the
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Figure 5.3: EF plotted against the varied simulation parameters. In each MC series, only
one parameter was varied, and the other parameters were set to the basic values respectively.
collimator is moved away from the source. However, variations in EF are below 1% for
the range under examination.
(f) Source size: EF decreases with increasing width of the Gaussian shaped source. For a
std of 0.15 mm, we calculated an EF of 0.48, which corresponds to a relative increase of
almost 10% in comparison to our basic std of 0.45 mm. For a std of 1.5 mm - the highest
value under examination - we calculated an EF of 0.30, which corresponds to a relative
decrease of approximately 32%. Figure 5.7 shows central lateral profiles of the energy
fluency scored for different source sizes.
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Figure 5.4: Energy fluency maps of MC series a (tilt X) and of the reference field.
5.2.4 Discussion
The primary radiation efficiency of the 2D-bMLC field is especially sensitive to a tilt of the
collimator perpendicular to the characteristic stripes of the field (tilt X). Already relatively
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Figure 5.5: Results for MC series a (tilt X). The averaged central lateral profiles of the energy
fluency in the isocentric plane is shown. For tilt angles greater than 0.5 degree, cross leakage
peaks appear outside the originally collimated field - at x approx. 47.5 and 57.5 mm.
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Figure 5.6: Results for MC series c (shift X). The averaged central lateral profiles of the
energy fluency in the isocentric plane is shown.
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Figure 5.7: Results for MC series f (source size). The averaged central lateral profiles of the
energy fluency in the isocentric plane is shown.
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small tilt angles lead to a significant decrease in EF, e.g. tilts of 0.1, 0.2 and 0.3 degrees leads
to relative decreases in EF of approximately 8%, 25% and 44% respectively. For angles greater
than 0.5 degree, the EF was merely about 5% of the EF of the un-tilted 2D-bMLC. Furthermore,
at these tilt angles unwanted energy fluency peaks appeared outside the actual field dimensions.
These peaks are a result of increased cross leakage through closed absorber channels. Also lateral
shifts perpendicular to the collimator slits (shift X) can lead to a significant reduction in the
primary radiation efficiency and, in addition, to an unwanted shift of the 2D-bMLC field. EF
is much less sensitive to tilts and shifts in parallel to the field stripes as well as to vertical shifts
towards the source or away from the source. Finally, in summary, the results show that correct
geometrical alignment of the 2D-bMLC is crucial and has to be performed with special care.
Based on geometrical considerations, one could also propose to change the design of the collima-
tor in order to make it at least a bit less sensitive to misalignments. For example the absorber
channels could be shortened and or the the source-collimator distance could be increased. How-
ever, these changes would also imply undesired consequences, such as increased leakage dose or
an increased minimum SAD.
EF also depends on the geometrical width of the photon source that is to say on the electron
beam spot on the target of the linear accelerator. To avoid losses in primary efficiency the
electron spot size should be as small as possible. Finally, for treatment planning a correct
model of the linac source is crucial.
5.2.5 Conclusion
Correct geometrical alignment of the 2D-bMLC is crucial and has to be performed with special
care. The primary radiation efficiency is especially sensitive to tilts and shifts perpendicular
to the 2D-bMLC-field stripes. Both can cause severe under-dosage. Furthermore, the primary
radiation efficiency decreases with increasing source size. A change of the source size can lead
to over- or under-dosage.
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5.3 Intrafraction Motion
5.3.1 Introduction
Patient motion during delivery of a radiotherapy (RT) fraction, called intrafraction motion, can
lead to degradations of the initial treatment plan. Any movements of the patient as well as of
the inner organs may cause discrepancies between the planned and the actually delivered doses.
First of all, motion typically results in a blurring of the dose distribution. A possible consequence
of the blurring is an underdosage at the borders of the target volume. Conventionally, this
problem is tackled by adjusting the margins of the planning target volume (PTV) appropriately.
However in IMRT, interplay between patient motions and the succesively applied or continuously
changing radiation fields may lead to hot and cold spots everywhere within the PTV, and
consequently also within the clinical target volume (CTV). These interplay effects depend on
the treatment technique and can be very compex. (Bortfeld et al., 2002, 2004; Yu et al., 1998).
2D-bMLC treatment might be notably sensitive to interplay effects, first because the treatments
are highly dynamic and secondly because of the striped pattern of the 2D-bMLC fields (see sec-
tions 2.3.1 and 3.3.2). In figure 5.8 we give an example for an interplay effect, which may occur
because of the spatial fractionation of the radiation fields. The figure should illustrates, why
2D-bMLC treatments might be especially prone to plan degradations induced by intrafraction
target motion. Of course, the example is over-simplistic in view of the fact that in practice the
2D-bMLC beams are divergent and the radiation is delivered quasi continuously meanwhile the
gantry rotates.
+
Field 1
+
Field 2
+
Cumulative doseIn between: No target motion 
(a) No target motion supposed (initial treatment plan)
+
Field 1
+
Field 2
+
Cumulative doseIn between: Target motion 
(b) The target has been displaced in between delivery of the fields.
+
gantry
Treatment design
Figure 5.8: Superposition of the dose deposited subsequently by opposing 2D-bMLC fields.
Interplay effects can arise, if the target volume is displaced in between the delivery of the
two fields. In practice, interplay effects occurring in a 2D-bMLC treatment should be highly
complex in view of the fact that radiation is delivered quasi continuously meanwhile the gantry
rotates.
This study represents a first investigation of dosimetric consequences of intrafraction motion
for 2D-bMLC prostate treatments. Therefore, the 4d MC tool (see section 3.3.3) was extended
to continuously modelled body displacements. Such as many other authors, we assumed that
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the patient moved as a rigid body (Adamson et al., 2011; Bortfeld et al., 2004; Langen et al.,
2008a; Li et al., 2008a).
In general, the dosimetric impact of interplay effects is reduced if doses are accumulated over
multiple fractions: The interplay effect is averaged out through fractionation3 (Bortfeld et al.,
2002). Dosimetric consequences of intrafraction motion for prostate IMRT, including interplay
effects, has been studied by several authors (Adamson et al., 2011; Langen et al., 2008a, 2012;
Li et al., 2008b). Consistently, the conclusion was, that significant motions could be observed
during individual fractions, but that the cumulative effect for a full treatment course is negligible
small.
In this study, we recalculated 2D-bMLC prostate plans with intrafraction motion for both
standard fractionation and for extreme hypofractionation. The assessed dose distributions
were compared to static reference plans. The applied motion patterns were assessed from
data recorded during prostate RT with the Calypso tumor tracking system (Varian Medical
Systems, Inc., Palo Alto, CA, USA). The Calypso system uses electromagnetic transponders
that are implanted into a tissue of interest. The positions of the transponders are localized and
continuously monitored with an antenna that is placed over the patient. If multiple transponders
(generally three) are implanted into the prostate, the Calypso system allows the observation
of real-time prostate movements during the course of RT (Balter et al., 2005; Kupelian et al.,
2007; Langen et al., 2008b; Lin et al., 2013; Schmitt et al., 2010; Willoughby et al., 2006).
Calypso localisation data has also already been used for motion-encoded dose reconstruction
for prostate treatments (Langen et al., 2012; Li et al., 2008a).
5.3.2 Methods
5.3.2.1 Motion data sets
The tumour motion data sets were assessed from data recorded with the Calypso system during
prostate IMRT treatments (the Calypso traces were not recorded for the same patient CTs, that
were finally used in the planning study). Three electromagnetic transponders implanted into
the prostate were tracked during each treatment fraction respectively. Data acquisition was
started after positioning of the patient and several minutes before first beam on. The relevant
quantity for our purposes was the mean 3d position of the transponders, from now on referred
to as the Calypso position. The acquisition rate of the Calypso position was 10 Hz. For this
study the Calypso data sets of two full treatment courses, both with 35 fractions, were used.
The recorded IMRT treatments were daily, without treating on weekends.
The Calypso position was used to model the displacement of the prostate during the delivery
of 2D-bMLC treatment fractions. We assumed patient setup with the Calypso system and
preprocessed the Calypso position fractionwise as follows: For each fraction a delivery start
time t0 was defined as the time of first beam on. Furthermore, a start position was defined as
the Calypso position averaged over the 30 s before first beam on. Finally, the 3d displacement
from the starting position over time was calculated, starting at t0.
In this way two motion data sets, each one consisting of the 3d displacement or motion pattern
for 35 fractions, were generated. In the following, the data sets are referred to as M1 and M2.
The motion patterns associated to a data set are labelled with the letter P and consecutive
numbers (e.g. M1 P12 is the pattern number 12 of data set M1). The numbers correspond
3Strictly speaking this is only true for the physical dose deposition but not for the biologically effective dose.
A non-even fractionation can lead to an additional biological effect. However, Bortfeld et al. (2002) showed that
this effect is generally negligible.
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to the treatment days of the originally recorded IMRT treatment. Two example for motion
patterns generated from the Calypso measurements are shown in figure 5.9.
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Figure 5.9: Motion patterns generated from measurements with the Calypso tumour track-
ing system. Two patterns with relatively pronounced intrafraction motion are shown. The
displacement components dx, dy and dz are given in the IEC patient system. In anatomical
terms of location, dx corresponds to the left/right axis, dy to the inferior/superior axis and dz
to the posterior/anterior axis.
5.3.2.2 2D-bMLC plans
The 2D-bMLC plans used for this study, and summarised in table 5.1, have already been
presented in chapter 3. For plan Boost (presented in section 3.3.4 as case 2), a multi-focal
simultaneous integrated boost concept was applied. The plans F35, F12 and F5 (section 4.4)
were all calculated for the same prostate patient but for different fractionation regimens, namely
for standard fractionation (F35) and for hypofractionation (F12 and F5). The fractional delivery
times TF were 20 s for Boost and F35, 40 s for F12 and 65 s for F5.
5.3.2.3 MC dose calculation with intrafraction motion
Each 2D-bMLC plan has been recalculated with the 4d MC tool without motion and with
different target motion patterns. In the MC simulations, target motion was modelled by dis-
placement of the treatment target point (TP). In section 3.3.3, the 4d MC dose calculation
method, has been described. For this study, the method was extended to time dependent TPs.
Therefore, the coordinates of the TP were also described as Time Features. As discussed in
detail in section 3.3.3, a function of time, called ‘Time Feature’, is associated to a simulation
quantity, which varies over time. A Time Feature assigns a well-specified value to any specific
time within the time range of the simulation.4
All MC plan recalculations are listed in table 5.1 in the last column. In the same column
we also specify the respectively applied motion patterns. (s) refers to static MC recalculation
without motion. (m1) and (m2) refer to full 2D-bMLC treatment courses computed with motion
4The 4d MC method was also extended to rotations of the patient geometry, although this freature was not
used for this study. TP displacements and arbitrary rotations of the patient geometry in the treatment room
can both be modelled continuously during the delivery of the 2D-bMLC treatment.
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Table 5.1: Plan Boost was presented in section 3.3.4 as case 2. The plans F35, F12 and F5 were
presented in section 4.4. Each plan has been recalculated with the 4d MC tool without motion
(s) and with different motion pattern. (m1) and (m2) refer to treatment courses computed with
patterns of the data sets M1 and M2 respectively. (m1∗) is a treatment fraction calculated with
M1 P12, the pattern with the highest std of the absolute target point displacement for TF 20 s.
(d1) and (d2) refer to constant drifts of 5 mm in inferior/superior (IS) and posterior/anterior
(PA) direction respectively.
Plan Prescription TF Series of motion patterns for MC
Boost D50% ≥ 20 s (s) static reference
34×2.25Gy (PTV boost) (m1) M1 P1–P34
34×1.50Gy (PTV LDP) (m2) M2 P1–P34
Single fractions:
(d1) drift PA
(d2) drift IS
(m1∗) M1 P12 (‘worst case’ fraction)
F35 D95% ≥ 35× 2.1Gy 20 s (s) static reference
(m1) M1 P1–P35
(m2) M2 P1–P35
F12 D95% ≥ 12× 4.3Gy 40 s (s) static reference
(m1) M1 P1–P12
(m2) M2 P1–P12
F5 D95% ≥ 5× 7.25Gy 65 s (s) static reference
(m1-a) M1 P1, P4, P6, P9, P11 ∗
(m1-b) M1 P2, P5, P7, P10, P12 ∗
(m2-a) M2 P1, P4, P6, P9, P11 ∗
(m2-b) M2 P2, P5, P7, P10, P12 ∗
Comment: The series correspond to potential treat-
ment schedules with two treatments per week resp.
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patterns of the data sets M1 and M2 respectively. The 2D-bMLC fractions were simulated with
the specified patterns separately, and finally, the fraction doses were summed up. Plan F5 is
delivered in only five fractions. This plan was recalculated twice for each motion data set,
but respectively with different combinations of motion patterns. Overall, the selected pattern
numbers correspond to realistic treatment schedules. As mentioned in section 5.3.2.1, the
patterns were recorded for daily RT (without weekend). Plans Boost, F35 and F12 would also
be delivered daily. Plan F5 would be delivered in two fractions a week following (RTOG, 2013).
For plan Boost, the dose distribution for pattern M1 P12, thus for a single treatment faction,
was evaluated separately (m1∗ in table 5.1). This is the motion pattern with the overall highest
std of the absolute TP displacement (see section 5.3.2.4) for TF 20 s. Additionally, treatments
fractions with constant drifts of the TP were simulated for the same plan (d1 and d2 in table
5.1). Within the delivery time of 20 s, the TP was shifted with constant speed by 5 mm
in superior/inferior (IS) or in posterior/anterior (PA) direction respectively. The shift was
performed from -2.5 mm to +2.5 mm in the respective direction and relative to the initially
planned TP.
F d>0.5dmax of all evaluated MC dose distributions was about 1%, whereas F d>0.5dmax is the
fractional uncertainty in the average dose for voxels with dose values greater than 50% of the
maximum dose (Chetty et al., 2007). The dose distributions were evaluated by means of visual
inspection and qualitative and quantitative DVH analysis. In this study, both PTV and CTV
doses were evaluated. Of course, the critical evaluation is that for the CTVs. The CTV to PTV
margin is the current management technique for interfraction and intrafraction motion. Hence,
degradations of the CTV doses should be prevented, but degradations of the PTV doses might
be allowed and are even expected.
5.3.2.4 Measure of motion
As measure of TP motion, the standard deviation of the absolute TP displacement was assessed
for each simulated treatment fraction and for each full treatment course. The displacement
pattern, which have been assessed from experimental data, are available as discrete data series:
displacement vectors (dxi, dyi, dzi) are assigned to the time points ti, which are sampled in
steps of 0.1 s starting at 0 s. The absolute displacement at time ti is given by
di =
(
dx2i + dy
2
i + dz
2
i
) 1
2 . (5.1)
The following textbook definition was used to calculate the std of a sample of absolute displace-
ments di:
std =
(
1
n− 1
n∑
i=1
(di − d¯)2
) 1
2
(5.2)
where
d¯ =
1
n
n∑
i=1
di (5.3)
and n is the number of elements in the sample. With equation 5.2, the standard deviation
can be assessed for all displacements modelled either in a single treatment fraction or in a full
treatment course, thus in a series of fractions. From now on, the standard deviation for a single
fraction is simply referred to as std, whereas the standard deviation for a full treatment course
is referred to as STD.
We want to emphasize, that the values of std or STD depend on the selected motion patterns
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as well as on the delivery time TF, and STD is furthermore directly affected by the number of
evaluated fractions. std and STD are proposed as metrics for the modelled motion. However,
these quantities cannot directly be correlated with physical properties. In this study, we will
only make comparisons between values of std or STD, which were assessed for well defined TF
and the same number of fractions.
std was also assessed for the constant drifts (d1) and (d2). Therefore, the drifts were described
by a series of displacement vectors sampled in steps of 0.1 s between 0 s and TF.
5.3.3 Results
5.3.3.1 Measure of motion
In figure 5.10, a bar plot is shown for each motion-encoded calculated treatment course. The
plots illustrate the distributions of std respectively. The values of STD are given in grey boxes,
which are added to each plot. As mentioned in section 5.3.2.4, we only make comparisons
between values assessed for the same TF and the same number of fractions.
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Figure 5.10: Standard deviation of the TP displacement. The values in the grey boxes are
STD assessed for full treatment courses. The bar plots show the distributions of std assessed
for individual treatment fractions. Boost and F35 are delivered in 35 fractions with TF 20
s, F12 in 12 fractions with TF 45 s and F5 in 5 fractions with TF 60 s. More details about
the treatment plans and the applied motion patterns are given in table 5.1. The arrow in (a)
points at the ‘worst case’ pattern M1 P12.
The plans Boost and F35 were both calculated for TF = 20 s. The same two series of motion
patterns (m1 and m2) were used for MC recalculation, whereas Boost was delivered in 34 and
F35 in 35 fractions. Finally, the bar plots (figure 5.10(a)) are very similar for both plans with
the sole difference of one count in the first bin. Comparing the to series, overall more higher
values of std have been assessed for series (m1). The highest value for (m2) is 0.6 mm, all other
35 values are below 0.5 mm. In comparison, for series (m1) seven values are above 0.5 mm
and 4 values above 1.0 mm. The by far highest value of 2.5 mm was assessed for fraction 12
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of (m1), respectively for motion pattern M1 P12. This fraction is also referred to as the ‘worst
case’ fraction related to intrafraction motion for TF = 20 s. As already mentioned in section
5.3.2.3, this is also the fraction, for which the dose distribution was evaluated separately in the
case of plan Boost.
In figure 5.10(a) and 5.10(b), we show the bar plots for the plans F12 and F5 with TF of 40
and 65 s respectively. Again, overall higher values of std and STD were assessed for the series
of motion patterns (m1), respectively (m1-a) and (m1-b) for F5.
5.3.3.2 Plan Boost
The quantitative DVH analysis for plan BOOST is shown in table 5.2. All dose values are given
relative to the prescription dose 76.5 Gy for the primary PTV (PTV boost). In the first column
of the table, the parameters assessed for the static reference plan (s) are given. In the other
columns of table 5.2, we report the DVH parameters for the MC calculations with intrafraction
motion. Differences to the static reference plan (s), which were seen as relevant, are encircled.
The DVH parameters assessed for the cumulative dose distributions are very similar to those
for the static reference. Overall, no relevant differences between the dose distribution calculated
with and without intrafraction motion can be reported, neither from DVH analysis nor from
visual inspection.
On the contrary, the distribution calculated for the so called ‘worst case’ fraction (m1∗) show
relatively large deviations from the static reference plan (s), especially for the primary target
(boost): The coverage of CTV boost was reduced to 88% compared to 100% as calculated for
the static plan. The minimum dose D98% was reduced by 6% and the maximum dose D2% was
increased by 8%. The target dose uniformity index was increased from 1.06 to 1.16. For the
considerably larger CTV LDP (the PTV volumes are given in table 3.1) the dose coverage was
reduced by 7%. Finally, D2% to the rectum was relatively increased by about 4%. In figure
5.11(a), we show plots of the DVHs for the CTVs and the PTVs.
In table 5.2, we also give the results for the treatment fractions calculated with constant TP
drifts. The drift in PA direction (d1) lead to expansive dosimetric consequences in the range
of those reported for (m1∗). Again, in the first instance the CTV doses were affected, as can
also be seen in the DVH plot in figure 5.11(b). The drift in IS direction (d2) did not lead to
relevant plan degradations. In fact, the coverage of PTV boost was reduced by 3%. However,
the DVH parameters assessed for the CTVs and the OARs were very similar to those of the
reference plan.
In figure 5.12, we compare dose distributions for the reference (s), the drift in PA direction (d1)
and the ‘worst case’ fraction (m1∗). Two slices with contours of PTV boost are shown: Slice 40
represents a centrally located cut through the volume; slice 47 is located at the superior edge
of PTV boost. On both slices, one can clearly see the dose inhomogeneities within PTV boost
introduced by the modelled motions: The dose distributions of (d1) and (m1∗) are characterised
by a ring-like pattern. For (m1∗), we noticed an additional overall reduction in the doses to PTV
boost on slice 47. However, CTV boost did not extend into slice 47 and was not considerably
affected by this dose reduction at the PTV edge.
5.3.3.3 Plans F35, F12 and F5
In table 5.3(a) to (c) we show the DVH parameters assessed for the treatment plans F35, F12
and F5 respectively. Differences to the static reference plan (s), which were seen as relevant,
are encircled. For F35 with 35 fractions and TF 20 s, no relevant differences could be observed
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Table 5.2: DVH analysis for plan Boost. The plan has been calculated with the 4d MC tool
without motion (s) and with motion patterns as described in table 5.1. Dose values are given
relative to the prescription dose for PTV boost (76.5Gy resp. 2.25Gy fraction dose). DVH
parameters are defined in section 3.3.4.
cumulative single fractions
(s) (m1) (m2) (m1∗) (d1) (d2)
std [mm] 0.0 0.8 0.5 2.5 1.5 1.5
PTV boost
D98% [%] 94 93 94 79 89 93
D98% [%] 104 104 104 110 111 104
V95% [%] 95 95 95 75 80 92
UI 1.09 1.09 1.09 1.29 1.20 1.10
CTV boost
D98% [%] 97 97 97 91 89 96
D2% [%] 104 104 104 112 113 104
V95% [%] 100 100 100 88 84 100
UI 1.06 1.06 1.06 1.18 1.21 1.07
PTV LDP
D98% [%] 61 61 61 59 60 61
D2% [%] 101 101 101 103 103 101
V95% [%] 95 95 95 87 90 94
UI 1.56 1.55 1.56 1.58 1.57 1.56
CTV LDP
D98% [%] 64 64 64 62 62 63
D2% [%] 102 102 102 104 104 102
V95% [%] 99 99 99 92 94 98
UI 1.55 1.55 1.55 1.59 1.58 1.56
Rectum
D2% [%] 95 95 95 99 96 95
Dmean [%] 43 43 43 45 43 43
Bladder
D2% [%] 102 102 102 100 105 101
Dmean [%] 51 52 52 47 51 51
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Figure 5.11: DVHs for fractions of plan Boost. The DVHs for (m1∗) and (d1) are shown in
comparison to the static plan (s). Dose values are given relative to the prescription dose for
PTV boost.
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Slice 40
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Figure 5.12: Dose maps for treatment fractions of Boost calculated without motion (s) with
a constant drift in PA direction (d1) and with motion pattern M1 P12 (m1∗). The superior
edge of PTV boost is shown on slice 47. The slice thickness is 2 mm. Dose values are shown
relative to the prescription for PTV boost. More details about the treatment plans and the
applied motion patterns are given in table 5.1.
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(a) Full treatment course: Accumulated dose maps for F5(m1-b) and for the static reference F5(s).
std 0.8 mm std 0.9 mm std 0.7 mm std 0.3 mm std 1.4 mm
(b) Fractions 1–5 of plan F5 (m1-b). Each fraction was calculated with a different motion pattern.
Figure 5.13: MC calculated dose maps for plan F5. All doses are shown relative to the
prescription dose, 7.25 Gy per fraction or 36.25 Gy for the full treatment course respectively.
More details about the treatment plans and the applied motion patterns are given in table 5.1.
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between the treatment courses calculated with intrafraction motion, (m1) and (m2), and the
reference (s). This is true for DVH analysis and visual inspection of the dose distributions. In
the case of plan F12 with 12 fractions and TF 40 s, variations in the DVH parameters reported
for the CTV and the OARs are below 1%.
Treatment plan F5 was delivered in only 5 fractions and with a TF of 65 s. With intrafraction
motion considered CTV coverage was between 94% for (m1-b) and 98% for (m2-a), compared
to 99% for (s). The target dose uniformity index - 1.05 for (s) - was slightly increased by
the motion, with the highest value of 1.08 for (m1-b). Overall for plan F5, (m1-b) was the
recalculation with the most critical deviations from the static reference. In figure 5.13 we show
dose distributions for F5(m1-b) and (s). The respective DVHs for the PTV and the CTV are
shown in figure 5.14.
Relevant differences concerning doses to the OARs between the references (s) and the respective
recalculations with motion could not be found, neither for F35, nor for the hypofractionated
plans F12 and F5.
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Figure 5.14: DVHs for plan F05: (m1-b) vs. (s). All doses are shown relative to the
prescription dose 36.25 Gy. More details about the treatment plans and the applied motion
patterns are given in table 5.1.
5.3.4 Discussion
Selection of motion patterns
Before going into the discussion of the results, we add a comment about the selection of the
motion patterns. As explained in detail in section 5.3.2.1, the patterns were generated from real
patient data recorded with the Calypso tumour tracking system during radiotherapy treatments.
Overall, Calypso data of more than 30 patient cases was available. For this study we selected
two data sets with relatively pronounced intrafraction motions within the first several minutes
after first beam on. The selection was based on visual inspection of the displacement curves
and not on a quantitative analysis. Certainly, only a limited number of cases was investigated
in this study. However, the results should provide a first insight into possible problems with
intrafraction motion for 2D-bMLC treatments.
Individual treatment fractions (and occurring interplay effects)
The MC dose distribution of individual treatment fractions calculated with intrafraction motion
can deviate significantly from the planned doses. This has been shown by the example of the
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Table 5.3: DVH analysis for prostate plan F35, F12 and F5. Doses are shown relative to the
prescription doses 73.5Gy, 51.0Gy and 36.25Gy resp. The plans have been calculated with
the 4d MC tool without motion (s) and with motion patterns as described in table 5.1. DVH
parameters are defined in section 3.3.4.
(a) Plan F35: 35 fractions, TF 20 s
(s) (m1) (m2)
std [mm] 0.0 0.8 0.5
PTV
D98% [%] 99 98 99
D2% [%] 109 108 109
V100% [%] 95 95 95
UI 1.08 1.08 1.08
CTV
D98% [%] 100 100 100
D2% [%] 109 109 109
V100% [%] 98 98 98
UI 1.07 1.07 1.07
Rectum
D2% [%] 97 97 97
Dmean [%] 33 33 33
Bladder
D2% [%] 103 103 103
Dmean [%] 14 14 14
(b) Plan F35: 35 fractions, TF 20 s
(s) (m1) (m2)
std [mm] 0.0 1.0 0.3
PTV
D98% [%] 99 98 98
D2% [%] 107 107 108
V100% [%] 95 94 94
UI 1.07 1.07 1.07
CTV
D98% [%] 100 100 99
D2% [%] 108 107 108
V100% [%] 98 99 97
UI 1.06 1.05 1.07
Rectum
D2% [%] 97 96 97
Dmean [%] 34 34 34
Bladder
D2% [%] 103 103 103
Dmean [%] 13 14 14
(c) Plan F5: 5 fractions, TF 65 s
(s) (m1-a) (m1-b) (m2-a) (m2-b)
std [mm] 0.0 1.3 1.1 0.3 0.4
PTV
D98% [%] 99 98 97 98 98
D2% [%] 107 108 108 107 108
V100% [%] 95 91 90 94 93
UI 1.06 1.08 1.09 1.07 1.07
CTV
D98% [%] 100 99 99 100 99
D2% [%] 107 108 109 107 108
V100% [%] 99 95 94 98 96
UI 1.05 1.07 1.08 1.06 1.07
Rectum
D2% [%] 97 97 97 97 97
Dmean [%] 36 35 36 35 35
Bladder
D2% [%] 103 102 102 103 103
Dmean [%] 13 14 13 13 14
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’worst case’ fraction (m1∗) for plan Boost. As can be seen in figure 5.12, the motion lead to
undesired dose inhomogeneities within the target volumes, most notably within the primary
target volume (PTV resp. CTV boost). The dosimetric consequences can be observed in the
DVHs shown in figure 5.11(a) and in the DVH parameters presented in table 5.2.
The reference dose distributions shown in figure 5.12 are rather flat within PTV boost. On the
contrary, the dose distributions of (m1∗) are characterized by a distinctive ringlike pattern in
the same region. The pattern araised around the axis of rotation of the 2D-bMLC treatment,
which is directed according to the normal of the shown slices and goes through the initially
planned TP (The TP was set close to the 3d center of PTV boost). We suppose that the ring-
shaped inhomogeneities are caused by interplay effects such as those which were mentioned in
the introduction in section 5.3.1 and for which an over-simplistic example was illustrated in
figure 5.8.
We further suppose that these inhomogeneities are primarily induced by displacements perpen-
dicular to the axis of rotation, thus in PA or LR direction. This latter supposition is based on
the principal geometry of the 2D-bMLC treatments, in particular on the orientation of the col-
limator according to the direction of gantry rotation (see section 3.3.1). The MC recalculations
(d1) and (d2) of plan Boost were performed to confirm the supposition. In simulation (d1), a
constant drift of the TP in PA direction was modelled during delivery. Consequently, this was
an example of displacement perpendicular to the axis of rotation. Dose distributions of (d1) are
also shown in figure 5.12. The drift lead to inhomogeneities in the dose distributions similar to
those observed for (m1∗). In simulation (d2), we modelled a constant drift in IS direction, thus
in parallel to the axis of rotation. The drift did not cause distinctive dose inhomogeneities.
Although displacements in IS direction might not lead to severe interplay effects, it is obvious
that they may cause insufficient target coverage at the superior and or the inferior extremity of
the PTV. Again, case (m1∗) gives an example for this effect. On slice 47, at the superior edge of
PTV boost, we observe an overall unintentional reduction of the dose. This reduction has also
considerably contributed to the divergence of the PTV boost DVHs of (m1∗) and (s), which
can be seen in figure 5.11(a). Finally, this dose reduction at the PTV edge did not considerably
affect the CTV doses.
A detailed analysis of individual treatment fractions was only performed for plan Boost and for
the discussed cases. However, here we also refer to figure 5.13(b). In the figure, we show MC
dose distributions calculated with intrafraction motion for the 5 treatment fractions of plan
F5 (TF 65 s). The statistical uncertainty of the MC simulations did not allow fractionwise
quantitative evaluation. However, we can observe further examples for dose inhomogeneities
within the target caused by intrafraction motion. Again ring-shaped textures are visible, in
three of the five shown dose maps.
Full treatment courses
The discussed inhomogeneities induced by intrafraction motion might appear dramatic, if dose
distributions of individual treatment fractions are analysed alone. Therefore, it is interesting
to take a closer look to the dose distributions accumulated over the full treatment courses.
They were assessed by summing up the ‘fractional’ dose distributions. This simple method of
dose accumulation was justified, because the MC calculations for one treatment course were all
performed with the same rigid patient geometry respectively. Only the patterns of (rigid) body
motion changed from fraction to fraction.
The plans Boost and F35 were both calculated for standard fractionation regimens and were
delivered in 34 and 35 fractions respectively. TF was 20 s in both cases. Based on the analysis
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of the accumulated doses for these two plans, we could not observe any plan degradations
induced by intrafraction motion. The motion in the ‘worst case’ fraction discussed above was
exceptionally pronounced. The value of std for this fraction was by far the highest value assessed
for TF = 20 s. Most of the other values were considerably smaller as can be seen in figure
5.10(a). Therefore, the dose inhomogeneities induced during the other fractions were certainly
less critical. In any case the inhomogeneities, including those of the ‘worst case’ fraction, were
finally averaged out in the accumulation over 34 respectively 35 treatment fractions. Overall,
in the case of standard fractionation the dosimetric consequences in the accumulated dose
distributions seem to be as small as those reported for other IMRT techniques by Langen et al.
(2008a, 2012) or Li et al. (2008b).
F12 and F5 were both hypofractionated treatment plans. The treatments were delivered in
less fractions (12 and 5 resp.) but with higher doses per fraction (4.3 and 7.25 Gy resp.).
We therefore expected that dose inhomogeneities, induced in single treatment fractions, should
carry more weight in the dose distribution for the full treatment course. The lower the number
of fractions, the more unlikely it should be that the inhomogeneities are averaged out. The
differences were still comparatively small for F12. Variations in the DVH parameters reported
for the CTV and the OARs were below 1%. However, in the case of plan F5, the dose distri-
butions calculated with intrafraction motion did indeed show significant differences from the
respective reference distributions. The CTV coverage was reduced by 1-4%. Moreover, the
PTV uniformity index UI was increased in all calculations with motion, albeit the increase was
relatively moderate. An increase in UI is evidence of enhanced dose inhomogeneity within a
target volume.
5.3.5 Conclusion
A model for rigid patient motion was successfully added to the time-dependent MC method
used for recalculation of 2D-bMLC treatments. The motion was modelled continuously during
treatment delivery. The method was used for the recalculation of prostate plans with clinically
recorded intrafraction motion patterns. Doses calculated for individual treatment fractions
did show distinctive deviations from the planned doses if intrafraction motion was considered.
However, in the case of standard fractionation and hypofractionation with 12 fractions, no
significant deviations could be observed for the doses accumulated over all fractions. Moderate
plan degradation was induced in the case of extreme hypofractionation with only 5 fractions.
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Summary and Conclusion
In this thesis, a novel collimator concept called the 2D-binary multileaf collimator (2D-bMLC)
was presented. The principal idea of the concept, which is specially dedicated to fast rotational
radiotherapy treatments, was to arrange absorber channels side by side in a 2D matrix to form
a radiation collimator. Individual control of each channel should allow for especially quick
aperture changes. To explore the capabilities of the concept a medical linac equipped with a
2D-bMLC was modelled and a treatment planning framework for 2D-bMLC treatments was
developed.
A detailed description of the 2D-bMLC design and the modelled treatment machine can be
found in chapter 2. The X-ray source of a modern flattening filter free medical linac was
modelled as well as an exemplary 2D-bMLC with 30 by 30 channels and a maximum field-size
of 30 by 30 cm2 in the isocentric plane. Because half of the radiation is always blocked in each
channel, the 2D-bMLC fields are inherently characterised by a striped pattern. In chapter 2, we
also presented the dosimetric model of the treatment machine that was successfully established
with a Monte-Carlo (MC) method. The primary radiation efficiency of the open 2D-bMLC
was 43%, the leakage of the closed one below 0.5%. Abutting bixel exhibited a slight tongue-
and-groove effect if opened sequentially. However, the effect was less pronounced than similar
tongue-and-groove effects exhibited by conventional MLCs. The equations presented in section
2.B.2 can be used to calculate theoretical projections of individual channel beams.
The planning framework for fast rotational 2D-bMLC treatments (chapter 3) is composed of
two individual tools. The optimization tool uses a newly developed method for inverse plan
optimization. The second tool is a MC framework for exact calculation of the dose. For the lat-
ter, a time-dependent MC method was implemented and a realistic model of the collimator and
gantry dynamic was included in the dose calculation. In order to test, if the 2D-bMLC concept
is in principal adequate for radiotherapy treatments a planning comparison was performed for
5 different clinical indications. The 2D-bMLC plans fulfilled the clinical goals, and dosimetric
parameters were comparable to those of clinically approved Tomotherapy plans. With a maxi-
mum dose rate of 2000 MU/min the scheduled delivery times of the 2D-bMLC treatments were
between 20 and 25 s.
The planning framework optimizes 2D-bMLC plans for one gantry rotation and for a pre-defined
fractional delivery time (TF). In order to examine in depth the influence of the delivery time
onto the final dose distribution, an additional planning study was performed. The study showed
that, below a critical TF, the target dose coverage drops down to a not clinical acceptable level.
However, above this value coverage was rather independent on TF. Furthermore, the potential
to spare the organs at risk was partly increased with accepting longer TF. Finally, a shorter
delivery time can lead to inferior optimisation results, and we concluded that a careful weighing
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up of shorter delivery time and better plan quality might be necessary for each clinical indication
or even each patient geometry.
The 2D-bMLC radiation fields are spatially fractionated into stripes and are formed by long
and thin absorber channels. Because of this special design, it could be speculated that 2D-
bMLC treatments might be notably sensitive to geometrical misalignments of the collimator
on the one hand, and to intrafraction motion on the other hand. Both aspects have been
investigated in the MC studies presented in the last chapter of this thesis. The first study
showed that the misalignment of the 2D-bMLC can in fact cause severe under-dosage. The
results suggest, that especially high demands on manufacture tolerances as well as on quality
assurance will be necessary, if a 2D-bMLC should be produced for clinical use. For the second
study, the MC tool was extended, so that rigid patient motion could be modelled continuously
during radiotherapy delivery. The new feature was used for the motion-encoded recalculation
of standard and of hypofractionated prostate plans. In the case of standard fractionation and
hypofractionation with 12 fractions, no significant plan degradation due to the motion could
be observed. Moderate plan degradation was induced in the case of extreme hypofractionation
with only 5 fractions.
Outlook
The work presented in this thesis showed that in principal the 2D-bMLC concept could be used
for fast rotational radiotherapy treatments with photons. In our opinion the most essential
questions that need to be answered next are, if the concept can be translated into the practice,
and if the high requirements on geometrical and mechanical precision can be fulfilled. The
future of the concept now depends on the answer to these questions.
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